The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma

Suzanne Baker, Jinghui Zhang and colleagues report the identification of recurrent somatic mutations in the bone morphogenetic protein (BMP) receptor ACVR1 in 32% of diffuse intrinsic pontine gliomas. Pediatric high-grade glioma (HGG) is a devastating disease with a less than 20% survival rate 2 yea...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Nature genetics Ročník 46; číslo 5; s. 444 - 450
Hlavní autoři: Wu, Gang, Diaz, Alexander K, Paugh, Barbara S, Rankin, Sherri L, Ju, Bensheng, Li, Yongjin, Zhu, Xiaoyan, Qu, Chunxu, Chen, Xiang, Zhang, Junyuan, Easton, John, Edmonson, Michael, Ma, Xiaotu, Lu, Charles, Nagahawatte, Panduka, Hedlund, Erin, Rusch, Michael, Pounds, Stanley, Lin, Tong, Onar-Thomas, Arzu, Huether, Robert, Kriwacki, Richard, Parker, Matthew, Gupta, Pankaj, Becksfort, Jared, Wei, Lei, Mulder, Heather L, Boggs, Kristy, Vadodaria, Bhavin, Yergeau, Donald, Russell, Jake C, Ochoa, Kerri, Fulton, Robert S, Fulton, Lucinda L, Jones, Chris, Boop, Frederick A, Broniscer, Alberto, Wetmore, Cynthia, Gajjar, Amar, Ding, Li, Mardis, Elaine R, Wilson, Richard K, Taylor, Michael R, Downing, James R, Ellison, David W, Zhang, Jinghui, Baker, Suzanne J
Médium: Journal Article
Jazyk:angličtina
Vydáno: New York Nature Publishing Group US 01.05.2014
Nature Publishing Group
Témata:
ISSN:1061-4036, 1546-1718, 1546-1718
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Suzanne Baker, Jinghui Zhang and colleagues report the identification of recurrent somatic mutations in the bone morphogenetic protein (BMP) receptor ACVR1 in 32% of diffuse intrinsic pontine gliomas. Pediatric high-grade glioma (HGG) is a devastating disease with a less than 20% survival rate 2 years after diagnosis 1 . We analyzed 127 pediatric HGGs, including diffuse intrinsic pontine gliomas (DIPGs) and non-brainstem HGGs (NBS-HGGs), by whole-genome, whole-exome and/or transcriptome sequencing. We identified recurrent somatic mutations in ACVR1 exclusively in DIPGs (32%), in addition to previously reported frequent somatic mutations in histone H3 genes, TP53 and ATRX , in both DIPGs and NBS-HGGs 2 , 3 , 4 , 5 . Structural variants generating fusion genes were found in 47% of DIPGs and NBS-HGGs, with recurrent fusions involving the neurotrophin receptor genes NTRK1, NTRK2 and NTRK3 in 40% of NBS-HGGs in infants. Mutations targeting receptor tyrosine kinase–RAS-PI3K signaling, histone modification or chromatin remodeling, and cell cycle regulation were found in 68%, 73% and 59% of pediatric HGGs, respectively, including in DIPGs and NBS-HGGs. This comprehensive analysis provides insights into the unique and shared pathways driving pediatric HGG within and outside the brainstem.
AbstractList Suzanne Baker, Jinghui Zhang and colleagues report the identification of recurrent somatic mutations in the bone morphogenetic protein (BMP) receptor ACVR1 in 32% of diffuse intrinsic pontine gliomas. Pediatric high-grade glioma (HGG) is a devastating disease with a less than 20% survival rate 2 years after diagnosis 1 . We analyzed 127 pediatric HGGs, including diffuse intrinsic pontine gliomas (DIPGs) and non-brainstem HGGs (NBS-HGGs), by whole-genome, whole-exome and/or transcriptome sequencing. We identified recurrent somatic mutations in ACVR1 exclusively in DIPGs (32%), in addition to previously reported frequent somatic mutations in histone H3 genes, TP53 and ATRX , in both DIPGs and NBS-HGGs 2 , 3 , 4 , 5 . Structural variants generating fusion genes were found in 47% of DIPGs and NBS-HGGs, with recurrent fusions involving the neurotrophin receptor genes NTRK1, NTRK2 and NTRK3 in 40% of NBS-HGGs in infants. Mutations targeting receptor tyrosine kinase–RAS-PI3K signaling, histone modification or chromatin remodeling, and cell cycle regulation were found in 68%, 73% and 59% of pediatric HGGs, respectively, including in DIPGs and NBS-HGGs. This comprehensive analysis provides insights into the unique and shared pathways driving pediatric HGG within and outside the brainstem.
Pediatric high-grade glioma (HGG) is a devastating disease with a less than 20% survival rate 2 years after diagnosis. We analyzed 127 pediatric HGGs, including diffuse intrinsic pontine gliomas (DIPGs) and non-brainstem HGGs (NBS-HGGs), by whole-genome, whole-exome and/or transcriptome sequencing. We identified recurrent somatic mutations in ACVR1 exclusively in DIPGs (32%), in addition to previously reported frequent somatic mutations in histone H3 genes, TP53 and ATRX, in both DIPGs and NBS-HGGs. Structural variants generating fusion genes were found in 47% of DIPGs and NBS-HGGs, with recurrent fusions involving the neurotrophin receptor genes NTRK1, NTRK2 and NTRK3 in 40% of NBS-HGGs in infants. Mutations targeting receptor tyrosine kinase-RAS-PI3K signaling, histone modification or chromatin remodeling, and cell cycle regulation were found in 68%, 73% and 59% of pediatric HGGs, respectively, including in DIPGs and NBS-HGGs. This comprehensive analysis provides insights into the unique and shared pathways driving pediatric HGG within and outside the brainstem. [PUBLICATION ABSTRACT]
Pediatric high-grade glioma (HGG) is a devastating disease with a less than 20% survival rate 2 years after diagnosis (1). We analyzed 127 pediatric HGGs, including diffuse intrinsic pontine gliomas (DIPGs) and non-brainstem HGGs (NBS-HGGs), by whole-genome, whole-exome and/or transcriptome sequencing. We identified recurrent somatic mutations in ACVR1 exclusively in DIPGs (32%), in addition to previously reported frequent somatic mutations in histone H3 genes, TP53 and ATRX, in both DIPGs and NBS-HGGs (2-5). Structural variants generating fusion genes were found in 47% of DIPGs and NBS-HGGs, with recurrent fusions involving the neurotrophin receptor genes NTRK1, NTRK2 and NTRK3 in 40% of NBS-HGGs in infants. Mutations targeting receptor tyrosine kinase-RAS-PI3K signaling, histone modification or chromatin remodeling, and cell cycle regulation were found in 68%, 73% and 59% of pediatric HGGs, respectively, including in DIPGs and NBS-HGGs. This comprehensive analysis provides insights into the unique and shared pathways driving pediatric HGG within and outside the brainstem.
Pediatric high-grade glioma (HGG) is a devastating disease with a less than 20% survival rate 2 years after diagnosis. We analyzed 127 pediatric HGGs, including diffuse intrinsic pontine gliomas (DIPGs) and non-brainstem HGGs (NBS-HGGs), by whole-genome, whole-exome and/or transcriptome sequencing. We identified recurrent somatic mutations in ACVR1 exclusively in DIPGs (32%), in addition to previously reported frequent somatic mutations in histone H3 genes, TP53 and ATRX, in both DIPGs and NBS-HGGs. Structural variants generating fusion genes were found in 47% of DIPGs and NBS-HGGs, with recurrent fusions involving the neurotrophin receptor genes NTRK1, NTRK2 and NTRK3 in 40% of NBS-HGGs in infants. Mutations targeting receptor tyrosine kinase-RAS-PI3K signaling, histone modification or chromatin remodeling, and cell cycle regulation were found in 68%, 73% and 59% of pediatric HGGs, respectively, including in DIPGs and NBS-HGGs. This comprehensive analysis provides insights into the unique and shared pathways driving pediatric HGG within and outside the brainstem.
Pediatric high-grade glioma (HGG) is a devastating disease with a two-year survival of less than 20%1. We analyzed 127 pediatric HGGs, including diffuse intrinsic pontine gliomas (DIPGs) and non-brainstem HGGs (NBS-HGGs) by whole genome, whole exome, and/or transcriptome sequencing. We identified recurrent somatic mutations in ACVR1 exclusively in DIPG (32%), in addition to the previously reported frequent somatic mutations in histone H3, TP53 and ATRX in both DIPG and NBS-HGGs2-5. Structural variants generating fusion genes were found in 47% of DIPGs and NBS-HGGs, with recurrent fusions involving the neurotrophin receptor genes NTRK1, 2, or 3 in 40% of NBS-HGGs in infants. Mutations targeting receptor tyrosine kinase/RAS/PI3K signaling, histone modification or chromatin remodeling, and cell cycle regulation were found in 68%, 73% and 59%, respectively, of pediatric HGGs, including DIPGs and NBS-HGGs. This comprehensive analysis provides insights into the unique and shared pathways driving pediatric HGG within and outside the brainstem.
Pediatric high-grade glioma (HGG) is a devastating disease with a less than 20% survival rate 2 years after diagnosis. We analyzed 127 pediatric HGGs, including diffuse intrinsic pontine gliomas (DIPGs) and non-brainstem HGGs (NBS-HGGs), by whole-genome, whole-exome and/or transcriptome sequencing. We identified recurrent somatic mutations in ACVR1 exclusively in DIPGs (32%), in addition to previously reported frequent somatic mutations in histone H3 genes, TP53 and ATRX, in both DIPGs and NBS-HGGs. Structural variants generating fusion genes were found in 47% of DIPGs and NBS-HGGs, with recurrent fusions involving the neurotrophin receptor genes NTRK1, NTRK2 and NTRK3 in 40% of NBS-HGGs in infants. Mutations targeting receptor tyrosine kinase-RAS-PI3K signaling, histone modification or chromatin remodeling, and cell cycle regulation were found in 68%, 73% and 59% of pediatric HGGs, respectively, including in DIPGs and NBS-HGGs. This comprehensive analysis provides insights into the unique and shared pathways driving pediatric HGG within and outside the brainstem.Pediatric high-grade glioma (HGG) is a devastating disease with a less than 20% survival rate 2 years after diagnosis. We analyzed 127 pediatric HGGs, including diffuse intrinsic pontine gliomas (DIPGs) and non-brainstem HGGs (NBS-HGGs), by whole-genome, whole-exome and/or transcriptome sequencing. We identified recurrent somatic mutations in ACVR1 exclusively in DIPGs (32%), in addition to previously reported frequent somatic mutations in histone H3 genes, TP53 and ATRX, in both DIPGs and NBS-HGGs. Structural variants generating fusion genes were found in 47% of DIPGs and NBS-HGGs, with recurrent fusions involving the neurotrophin receptor genes NTRK1, NTRK2 and NTRK3 in 40% of NBS-HGGs in infants. Mutations targeting receptor tyrosine kinase-RAS-PI3K signaling, histone modification or chromatin remodeling, and cell cycle regulation were found in 68%, 73% and 59% of pediatric HGGs, respectively, including in DIPGs and NBS-HGGs. This comprehensive analysis provides insights into the unique and shared pathways driving pediatric HGG within and outside the brainstem.
Audience Academic
Author Wilson, Richard K
Lu, Charles
Pounds, Stanley
Ma, Xiaotu
Taylor, Michael R
Edmonson, Michael
Jones, Chris
Baker, Suzanne J
Onar-Thomas, Arzu
Boop, Frederick A
Easton, John
Qu, Chunxu
Vadodaria, Bhavin
Zhang, Jinghui
Nagahawatte, Panduka
Mardis, Elaine R
Zhang, Junyuan
Ju, Bensheng
Wetmore, Cynthia
Kriwacki, Richard
Fulton, Robert S
Becksfort, Jared
Wu, Gang
Ding, Li
Mulder, Heather L
Huether, Robert
Lin, Tong
Ochoa, Kerri
Diaz, Alexander K
Paugh, Barbara S
Fulton, Lucinda L
Downing, James R
Rusch, Michael
Russell, Jake C
Wei, Lei
Yergeau, Donald
Gajjar, Amar
Gupta, Pankaj
Li, Yongjin
Chen, Xiang
Broniscer, Alberto
Rankin, Sherri L
Parker, Matthew
Ellison, David W
Boggs, Kristy
Zhu, Xiaoyan
Hedlund, Erin
AuthorAffiliation 3 Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN 38163
7 Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN 38105
8 Department of Structural Biology, St. Jude Children’s Research Hospital, Memphis, TN 38105
10 Division of Molecular Pathology, Institute for Cancer Research, London, UK SM2 5NG
6 The Genome Institute, Washington University, 633108
14 Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN 38105
12 Department of Surgery, St. Jude Children’s Research Hospital, Memphis, TN 38105
2 Department of Developmental Neurobiology, St. Jude Children’s Research Hospital, Memphis, TN 38105
4 Department of Chemical Biology and Therapeutics, St. Jude Children’s Research Hospital, Memphis, TN 38105
1 Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN 38105
5 Department of Pediatric Cancer Genome Project, St. Jude Children’s Research Hospital, Memphis, TN 38105
9 Bi
AuthorAffiliation_xml – name: 11 Division of Cancer Therapeutics, Institute for Cancer Research, London, UK SM2 5NG
– name: 8 Department of Structural Biology, St. Jude Children’s Research Hospital, Memphis, TN 38105
– name: 7 Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN 38105
– name: 5 Department of Pediatric Cancer Genome Project, St. Jude Children’s Research Hospital, Memphis, TN 38105
– name: 4 Department of Chemical Biology and Therapeutics, St. Jude Children’s Research Hospital, Memphis, TN 38105
– name: 1 Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN 38105
– name: 9 Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY 14263
– name: 13 Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN 38105
– name: 10 Division of Molecular Pathology, Institute for Cancer Research, London, UK SM2 5NG
– name: 2 Department of Developmental Neurobiology, St. Jude Children’s Research Hospital, Memphis, TN 38105
– name: 6 The Genome Institute, Washington University, 633108
– name: 12 Department of Surgery, St. Jude Children’s Research Hospital, Memphis, TN 38105
– name: 3 Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN 38163
– name: 14 Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN 38105
Author_xml – sequence: 1
  givenname: Gang
  surname: Wu
  fullname: Wu, Gang
  organization: Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 2
  givenname: Alexander K
  surname: Diaz
  fullname: Diaz, Alexander K
  organization: Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN 38163
– sequence: 3
  givenname: Barbara S
  surname: Paugh
  fullname: Paugh, Barbara S
  organization: Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 4
  givenname: Sherri L
  surname: Rankin
  fullname: Rankin, Sherri L
  organization: Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 5
  givenname: Bensheng
  surname: Ju
  fullname: Ju, Bensheng
  organization: Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 6
  givenname: Yongjin
  surname: Li
  fullname: Li, Yongjin
  organization: Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 7
  givenname: Xiaoyan
  surname: Zhu
  fullname: Zhu, Xiaoyan
  organization: Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 8
  givenname: Chunxu
  surname: Qu
  fullname: Qu, Chunxu
  organization: Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 9
  givenname: Xiang
  surname: Chen
  fullname: Chen, Xiang
  organization: Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 10
  givenname: Junyuan
  surname: Zhang
  fullname: Zhang, Junyuan
  organization: Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 11
  givenname: John
  surname: Easton
  fullname: Easton, John
  organization: Department of Pediatric Cancer Genome Project, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 12
  givenname: Michael
  surname: Edmonson
  fullname: Edmonson, Michael
  organization: Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 13
  givenname: Xiaotu
  surname: Ma
  fullname: Ma, Xiaotu
  organization: Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 14
  givenname: Charles
  surname: Lu
  fullname: Lu, Charles
  organization: The Genome Institute, Washington University, 633108
– sequence: 15
  givenname: Panduka
  surname: Nagahawatte
  fullname: Nagahawatte, Panduka
  organization: Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 16
  givenname: Erin
  surname: Hedlund
  fullname: Hedlund, Erin
  organization: Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 17
  givenname: Michael
  surname: Rusch
  fullname: Rusch, Michael
  organization: Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 18
  givenname: Stanley
  surname: Pounds
  fullname: Pounds, Stanley
  organization: Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 19
  givenname: Tong
  surname: Lin
  fullname: Lin, Tong
  organization: Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 20
  givenname: Arzu
  surname: Onar-Thomas
  fullname: Onar-Thomas, Arzu
  organization: Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 21
  givenname: Robert
  surname: Huether
  fullname: Huether, Robert
  organization: Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 22
  givenname: Richard
  surname: Kriwacki
  fullname: Kriwacki, Richard
  organization: Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 23
  givenname: Matthew
  surname: Parker
  fullname: Parker, Matthew
  organization: Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 24
  givenname: Pankaj
  surname: Gupta
  fullname: Gupta, Pankaj
  organization: Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 25
  givenname: Jared
  surname: Becksfort
  fullname: Becksfort, Jared
  organization: Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 26
  givenname: Lei
  surname: Wei
  fullname: Wei, Lei
  organization: Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY 14263
– sequence: 27
  givenname: Heather L
  surname: Mulder
  fullname: Mulder, Heather L
  organization: Department of Pediatric Cancer Genome Project, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 28
  givenname: Kristy
  surname: Boggs
  fullname: Boggs, Kristy
  organization: Department of Pediatric Cancer Genome Project, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 29
  givenname: Bhavin
  surname: Vadodaria
  fullname: Vadodaria, Bhavin
  organization: Department of Pediatric Cancer Genome Project, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 30
  givenname: Donald
  surname: Yergeau
  fullname: Yergeau, Donald
  organization: Department of Pediatric Cancer Genome Project, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 31
  givenname: Jake C
  surname: Russell
  fullname: Russell, Jake C
  organization: Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 32
  givenname: Kerri
  surname: Ochoa
  fullname: Ochoa, Kerri
  organization: The Genome Institute, Washington University, 633108
– sequence: 33
  givenname: Robert S
  surname: Fulton
  fullname: Fulton, Robert S
  organization: The Genome Institute, Washington University, 633108
– sequence: 34
  givenname: Lucinda L
  surname: Fulton
  fullname: Fulton, Lucinda L
  organization: The Genome Institute, Washington University, 633108
– sequence: 35
  givenname: Chris
  surname: Jones
  fullname: Jones, Chris
  organization: Division of Cancer Therapeutics, Institute for Cancer Research, London, UK SM2 5NG
– sequence: 36
  givenname: Frederick A
  surname: Boop
  fullname: Boop, Frederick A
  organization: Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 37
  givenname: Alberto
  surname: Broniscer
  fullname: Broniscer, Alberto
  organization: Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 38
  givenname: Cynthia
  surname: Wetmore
  fullname: Wetmore, Cynthia
  organization: Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 39
  givenname: Amar
  surname: Gajjar
  fullname: Gajjar, Amar
  organization: Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 40
  givenname: Li
  surname: Ding
  fullname: Ding, Li
  organization: The Genome Institute, Washington University, 633108
– sequence: 41
  givenname: Elaine R
  surname: Mardis
  fullname: Mardis, Elaine R
  organization: The Genome Institute, Washington University, 633108
– sequence: 42
  givenname: Richard K
  surname: Wilson
  fullname: Wilson, Richard K
  organization: The Genome Institute, Washington University, 633108
– sequence: 43
  givenname: Michael R
  surname: Taylor
  fullname: Taylor, Michael R
  organization: Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 44
  givenname: James R
  surname: Downing
  fullname: Downing, James R
  organization: Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 45
  givenname: David W
  surname: Ellison
  fullname: Ellison, David W
  organization: Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 46
  givenname: Jinghui
  surname: Zhang
  fullname: Zhang, Jinghui
  organization: Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105
– sequence: 47
  givenname: Suzanne J
  surname: Baker
  fullname: Baker, Suzanne J
  organization: Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN 38163
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24705251$$D View this record in MEDLINE/PubMed
BookMark eNqN0k1r3DAQBmBRUppkW_oPiqGHtgdvJVmS7UsghH4EAoE27VXI8sirYEtbyy7tv-8s2S272x6CDzaeR4N4Z87JSYgBCHnJ6JLRonofuiWvi-oJOWNSqJyVrDrBb6pYLmihTsl5SveUMiFo9YycclFSySU7I93dCrIOQhy8zXoT2mTNGrLostY7NyfIfJhGHxKW1zFMPiDvfRxMhjhbQ-sN1m2GF8qb0aCcYMhWvlvl3WjanX5OnjrTJ3ixfS_It48f7q4-5ze3n66vLm9yq5SYcmMraBQ0TWEqV9eGlRassU4y2lKuQKrCWMoY543kgjraSFCuLGzRWlWysliQi4e-67kZoLWAtze9Xo9-MONvHY3Xh5XgV7qLP7WgUgnJscHbbYMx_pghTXrwyUKP2UCck2ZSilpyyh9DWV0JLnECC_L6iN7HeQyYBCqcBit4tac604P2wUW8ot001ZeFqmhZCFqjWv5H4dMCDhH3wnn8f3Dg3cEBNBP8mjozp6Svv355vL39fmhf7Wf9N-TddiHIH4AdY0ojOG39ZCYfN9H7XjOqN9urQ6c324v-zZHftfxXbqNPKEIH416eR_QPtuv5wA
CitedBy_id crossref_primary_10_1007_s00701_018_3673_y
crossref_primary_10_1177_03008916221099067
crossref_primary_10_1007_s10147_023_02345_7
crossref_primary_10_1016_j_pathol_2023_05_002
crossref_primary_10_1007_s11523_022_00909_7
crossref_primary_10_1038_s41416_018_0251_2
crossref_primary_10_1093_neuonc_noab200
crossref_primary_10_1093_neuonc_noz108
crossref_primary_10_1016_j_ccell_2020_12_003
crossref_primary_10_1136_bcr_2021_246423
crossref_primary_10_1038_s41467_018_06485_7
crossref_primary_10_1101_gad_255182_114
crossref_primary_10_25259_SNI_405_2023
crossref_primary_10_3389_fonc_2022_922928
crossref_primary_10_1007_s12094_021_02558_0
crossref_primary_10_1093_neuonc_noy131
crossref_primary_10_1038_ng_2970
crossref_primary_10_2217_fon_2017_0003
crossref_primary_10_1111_bpa_12747
crossref_primary_10_1002_hed_28058
crossref_primary_10_1016_j_ejca_2019_03_019
crossref_primary_10_1016_j_humgen_2025_201476
crossref_primary_10_1038_s41467_022_28198_8
crossref_primary_10_1097_PAP_0000000000000186
crossref_primary_10_1158_2159_8290_CD_20_0930
crossref_primary_10_7554_eLife_41637
crossref_primary_10_1016_j_neurol_2023_03_016
crossref_primary_10_1016_j_jmb_2016_11_019
crossref_primary_10_1186_s12974_022_02630_8
crossref_primary_10_1007_s00401_022_02405_8
crossref_primary_10_3171_2018_6_PEDS17658
crossref_primary_10_5858_arpa_2021_0295_CP
crossref_primary_10_1080_2162402X_2022_2124058
crossref_primary_10_1007_s00401_019_02072_2
crossref_primary_10_3390_dermatopathology11010010
crossref_primary_10_1186_s40478_021_01270_y
crossref_primary_10_1200_JCO_2014_58_3922
crossref_primary_10_1101_gad_309013_117
crossref_primary_10_1038_s41591_019_0373_y
crossref_primary_10_1007_s11912_014_0436_7
crossref_primary_10_1038_s41467_024_48214_3
crossref_primary_10_1016_j_pathol_2015_12_007
crossref_primary_10_1159_000529099
crossref_primary_10_1002_2211_5463_13730
crossref_primary_10_3390_cancers16010232
crossref_primary_10_1007_s00381_017_3431_0
crossref_primary_10_1093_neuonc_now181
crossref_primary_10_1016_j_prp_2022_153995
crossref_primary_10_1158_1541_7786_MCR_16_0389
crossref_primary_10_1093_jnen_nlab016
crossref_primary_10_1097_PAP_0000000000000393
crossref_primary_10_1101_cshperspect_a022327
crossref_primary_10_1186_s40478_024_01818_8
crossref_primary_10_1007_s11910_020_01041_7
crossref_primary_10_3389_fonc_2021_701113
crossref_primary_10_1002_ardp_202200438
crossref_primary_10_1016_j_ejca_2016_04_001
crossref_primary_10_3390_cancers10040105
crossref_primary_10_1007_s11060_025_04954_w
crossref_primary_10_1038_s41467_019_13825_8
crossref_primary_10_3390_diagnostics11030481
crossref_primary_10_1016_j_bone_2020_115469
crossref_primary_10_1093_nop_npaf015
crossref_primary_10_1016_j_bbcan_2023_188951
crossref_primary_10_1080_14728222_2018_1487953
crossref_primary_10_1038_s41591_019_0383_9
crossref_primary_10_1016_j_jconrel_2018_05_005
crossref_primary_10_1093_neuonc_nox021
crossref_primary_10_1007_s10014_021_00411_4
crossref_primary_10_1093_neuonc_nox022
crossref_primary_10_1007_s10555_020_09850_5
crossref_primary_10_1158_1078_0432_CCR_18_0924
crossref_primary_10_1007_s10014_017_0282_z
crossref_primary_10_1111_neup_12892
crossref_primary_10_1007_s00428_017_2181_4
crossref_primary_10_1111_bpa_12720
crossref_primary_10_3389_fonc_2015_00172
crossref_primary_10_3390_cancers15133532
crossref_primary_10_1038_s41467_021_24836_9
crossref_primary_10_1111_bpa_12729
crossref_primary_10_1186_s13000_019_0793_5
crossref_primary_10_1093_neuonc_noaa101
crossref_primary_10_1093_neuonc_noz218
crossref_primary_10_3171_2015_6_PEDS15374
crossref_primary_10_1038_s41588_022_01205_w
crossref_primary_10_1038_s41467_019_11732_6
crossref_primary_10_1186_s40478_014_0134_6
crossref_primary_10_1016_j_bone_2017_11_001
crossref_primary_10_1093_neuonc_nox158
crossref_primary_10_1093_neuonc_noy123
crossref_primary_10_1177_0883073820931635
crossref_primary_10_1093_neuonc_noz150
crossref_primary_10_1186_s40478_021_01184_9
crossref_primary_10_1148_radiol_2019190491
crossref_primary_10_1016_S1634_7072_24_50006_X
crossref_primary_10_1002_pbc_30513
crossref_primary_10_1308_rcsann_2019_0111
crossref_primary_10_1016_j_it_2019_05_009
crossref_primary_10_1186_s40478_024_01817_9
crossref_primary_10_1016_j_job_2017_03_004
crossref_primary_10_1038_s41467_019_08823_9
crossref_primary_10_1097_MPH_0000000000000551
crossref_primary_10_1097_PAS_0000000000000675
crossref_primary_10_1007_s00381_015_2832_1
crossref_primary_10_1111_apm_12916
crossref_primary_10_1002_pbc_26026
crossref_primary_10_1155_2022_5021758
crossref_primary_10_1093_neuonc_noz022
crossref_primary_10_1093_neuonc_noz021
crossref_primary_10_3390_cancers15194869
crossref_primary_10_1093_neuonc_noy070
crossref_primary_10_1097_MPH_0000000000001417
crossref_primary_10_1007_s10147_019_01610_y
crossref_primary_10_3389_fcell_2022_1089898
crossref_primary_10_1042_BST20201227
crossref_primary_10_1016_j_genrep_2020_100885
crossref_primary_10_1016_j_bbrc_2017_08_016
crossref_primary_10_1186_s40478_020_01000_w
crossref_primary_10_1111_nan_12915
crossref_primary_10_1038_s41417_024_00809_0
crossref_primary_10_1159_000531040
crossref_primary_10_1073_pnas_1605523113
crossref_primary_10_1038_s41467_023_38746_5
crossref_primary_10_1186_s12943_024_02027_6
crossref_primary_10_1111_cas_15363
crossref_primary_10_3390_jcm12165261
crossref_primary_10_1093_jnen_nlv009
crossref_primary_10_7554_eLife_13463
crossref_primary_10_1136_jclinpath_2018_205679
crossref_primary_10_3389_fonc_2020_593578
crossref_primary_10_1007_s12672_025_02581_5
crossref_primary_10_1158_1541_7786_MCR_15_0477
crossref_primary_10_1111_boc_201400096
crossref_primary_10_1038_ncomms11185
crossref_primary_10_1002_wdev_342
crossref_primary_10_1158_0008_5472_CAN_22_0671
crossref_primary_10_1038_nature25480
crossref_primary_10_1097_MPH_0000000000001983
crossref_primary_10_3390_pharmaceutics12100948
crossref_primary_10_1016_j_spen_2014_12_004
crossref_primary_10_1016_j_spen_2014_12_003
crossref_primary_10_1038_s41598_023_48652_x
crossref_primary_10_1016_j_pediatrneurol_2019_08_004
crossref_primary_10_1038_s41467_021_21255_8
crossref_primary_10_1038_s41467_020_15084_4
crossref_primary_10_1016_j_critrevonc_2021_103564
crossref_primary_10_3389_fonc_2022_1082062
crossref_primary_10_3390_ijms21186763
crossref_primary_10_3390_ijms222011292
crossref_primary_10_1158_0008_5472_CAN_24_2227
crossref_primary_10_1177_2632010X231197080
crossref_primary_10_7554_eLife_36696
crossref_primary_10_1111_nan_12802
crossref_primary_10_3390_cancers14030712
crossref_primary_10_3390_cancers13225678
crossref_primary_10_3390_vetsci12080747
crossref_primary_10_1148_rg_2018180109
crossref_primary_10_1186_s12951_019_0483_1
crossref_primary_10_3389_fonc_2025_1555986
crossref_primary_10_1002_pmic_201800479
crossref_primary_10_3389_fonc_2023_1235794
crossref_primary_10_1155_2022_3436631
crossref_primary_10_3390_cancers13246251
crossref_primary_10_1200_JCO_2017_73_0242
crossref_primary_10_1371_journal_pcbi_1005711
crossref_primary_10_1177_0883073815601495
crossref_primary_10_3389_fonc_2022_1104129
crossref_primary_10_1186_s40478_017_0440_x
crossref_primary_10_3390_ijms26094104
crossref_primary_10_1016_j_phoj_2023_02_003
crossref_primary_10_1016_j_modpat_2023_100180
crossref_primary_10_1093_neuonc_noaa024
crossref_primary_10_1093_neuonc_noac202
crossref_primary_10_1002_path_6084
crossref_primary_10_1002_pbc_26593
crossref_primary_10_1038_s41568_024_00684_9
crossref_primary_10_1186_s40478_018_0553_x
crossref_primary_10_1002_pbc_25266
crossref_primary_10_1097_WCO_0000000000000991
crossref_primary_10_1186_s40478_022_01463_z
crossref_primary_10_1002_pbc_29746
crossref_primary_10_3389_fnins_2023_1129434
crossref_primary_10_1038_nm_4320
crossref_primary_10_1016_j_conb_2017_10_009
crossref_primary_10_1186_s40478_018_0602_5
crossref_primary_10_1038_s43856_025_00901_y
crossref_primary_10_1158_1078_0432_CCR_19_0126
crossref_primary_10_1038_nm_4204
crossref_primary_10_1016_j_ejmech_2017_04_047
crossref_primary_10_1186_s13059_020_02043_x
crossref_primary_10_1371_journal_pone_0193565
crossref_primary_10_1016_j_cancergen_2022_01_003
crossref_primary_10_1016_j_pharmthera_2017_02_006
crossref_primary_10_1016_j_cancergen_2022_01_004
crossref_primary_10_3390_biomedicines9070736
crossref_primary_10_1007_s00401_018_1842_y
crossref_primary_10_1016_S1470_2045_15_00388_5
crossref_primary_10_1007_s11060_022_04027_2
crossref_primary_10_1016_j_modpat_2025_100752
crossref_primary_10_1177_0883073815579709
crossref_primary_10_3390_cancers15174246
crossref_primary_10_1038_s41467_020_16682_y
crossref_primary_10_1111_bpa_12484
crossref_primary_10_1002_cncr_34156
crossref_primary_10_1016_j_drudis_2021_12_016
crossref_primary_10_3390_molecules27092685
crossref_primary_10_1186_s12915_022_01324_0
crossref_primary_10_1186_s12967_022_03522_4
crossref_primary_10_1016_j_jgg_2018_04_004
crossref_primary_10_1002_bmc_4697
crossref_primary_10_1016_j_tcb_2021_05_006
crossref_primary_10_1186_s13148_021_01057_x
crossref_primary_10_1177_2329048X221146982
crossref_primary_10_1146_annurev_cellbio_100913_013311
crossref_primary_10_1016_j_canlet_2024_216876
crossref_primary_10_1158_0008_5472_CAN_18_3441
crossref_primary_10_1073_pnas_1418996111
crossref_primary_10_1016_j_ejca_2025_115230
crossref_primary_10_3389_fgene_2020_604336
crossref_primary_10_1186_s40478_021_01296_2
crossref_primary_10_1097_PAP_0000000000000225
crossref_primary_10_1038_s41467_019_09140_x
crossref_primary_10_1139_gen_2020_0097
crossref_primary_10_1038_s43018_022_00403_z
crossref_primary_10_1111_bpa_12473
crossref_primary_10_1158_1078_0432_CCR_18_1156
crossref_primary_10_3389_fonc_2024_1504440
crossref_primary_10_1042_BST20190315
crossref_primary_10_1007_s11060_021_03890_9
crossref_primary_10_1007_s00401_015_1532_y
crossref_primary_10_1002_path_4813
crossref_primary_10_1080_14737140_2019_1538796
crossref_primary_10_1111_bpa_12336
crossref_primary_10_1002_cam4_6647
crossref_primary_10_1038_s41388_021_02102_y
crossref_primary_10_1186_s13073_017_0468_3
crossref_primary_10_1186_s40478_015_0269_0
crossref_primary_10_1158_2159_8290_CD_18_0953
crossref_primary_10_1158_1078_0432_CCR_14_0833
crossref_primary_10_1007_s00432_024_06077_7
crossref_primary_10_1038_s41375_019_0576_8
crossref_primary_10_1158_2159_8290_CD_16_1237
crossref_primary_10_3390_diagnostics12020372
crossref_primary_10_1186_s40001_025_02306_y
crossref_primary_10_1016_j_ccell_2018_04_004
crossref_primary_10_1038_nn_4190
crossref_primary_10_3390_genes14061201
crossref_primary_10_1016_j_ebiom_2021_103453
crossref_primary_10_1038_nrclinonc_2016_204
crossref_primary_10_1227_neu_0000000000003527
crossref_primary_10_7554_eLife_91313_3
crossref_primary_10_1002_path_4701
crossref_primary_10_1097_MOP_0000000000000975
crossref_primary_10_1016_j_beha_2017_07_003
crossref_primary_10_15252_embj_2020106317
crossref_primary_10_1515_revneuro_2022_0060
crossref_primary_10_1016_j_ejpb_2021_12_007
crossref_primary_10_1097_PAS_0000000000001377
crossref_primary_10_1111_bph_15034
crossref_primary_10_1111_joim_12690
crossref_primary_10_3390_cancers12010147
crossref_primary_10_1007_s00401_015_1410_7
crossref_primary_10_1038_s41467_018_03476_6
crossref_primary_10_1038_s42003_021_02647_4
crossref_primary_10_1093_neuonc_now101
crossref_primary_10_1111_bpa_12210
crossref_primary_10_3390_biomedicines9020155
crossref_primary_10_1038_s41588_023_01640_3
crossref_primary_10_1038_s41390_025_03847_y
crossref_primary_10_1016_j_jocn_2020_10_005
crossref_primary_10_1007_s00401_015_1478_0
crossref_primary_10_3389_fmolb_2024_1469775
crossref_primary_10_1016_j_molcel_2016_05_004
crossref_primary_10_1158_1078_0432_CCR_19_3714
crossref_primary_10_1158_1541_7786_MCR_20_0099
crossref_primary_10_3390_vetsci10060403
crossref_primary_10_3389_fcell_2022_883523
crossref_primary_10_1007_s00401_018_1877_0
crossref_primary_10_1016_j_mrrev_2025_108537
crossref_primary_10_1155_2016_7290686
crossref_primary_10_1038_s44320_023_00001_w
crossref_primary_10_1093_neuonc_now277
crossref_primary_10_1007_s00401_017_1710_1
crossref_primary_10_1007_s11060_017_2372_5
crossref_primary_10_1146_annurev_pathol_012615_044208
crossref_primary_10_1016_j_semcancer_2017_11_010
crossref_primary_10_1093_neuonc_now274
crossref_primary_10_1038_s41389_017_0012_8
crossref_primary_10_1038_s41598_020_67764_2
crossref_primary_10_1158_0008_5472_CAN_16_2482
crossref_primary_10_3390_cancers12092542
crossref_primary_10_1186_s40478_018_0570_9
crossref_primary_10_3389_fonc_2024_1382394
crossref_primary_10_1007_s00109_015_1260_8
crossref_primary_10_1200_JCO_2017_75_9308
crossref_primary_10_3390_ijms21249654
crossref_primary_10_1007_s00330_021_07991_x
crossref_primary_10_1007_s12672_024_01402_5
crossref_primary_10_1016_j_bbcan_2017_12_003
crossref_primary_10_1007_s00401_016_1568_7
crossref_primary_10_2217_fon_2016_0039
crossref_primary_10_1016_j_devcel_2022_12_011
crossref_primary_10_1093_nop_npu022
crossref_primary_10_1016_j_critrevonc_2023_104188
crossref_primary_10_1016_j_humpath_2018_04_015
crossref_primary_10_1016_j_beha_2018_09_003
crossref_primary_10_1016_j_dib_2016_06_060
crossref_primary_10_1146_annurev_cancerbio_062722_034650
crossref_primary_10_1038_s41598_021_84513_1
crossref_primary_10_1093_neuonc_noaa200
crossref_primary_10_3390_cancers14235967
crossref_primary_10_1111_nan_12196
crossref_primary_10_1016_j_ejca_2025_115308
crossref_primary_10_1007_s00401_019_01975_4
crossref_primary_10_1080_15265161_2017_1284936
crossref_primary_10_1016_j_ncl_2018_04_009
crossref_primary_10_1038_s41568_019_0226_5
crossref_primary_10_1111_bpa_12776
crossref_primary_10_3389_fcell_2020_00546
crossref_primary_10_1007_s00401_016_1579_4
crossref_primary_10_1038_s41379_021_00841_7
crossref_primary_10_1007_s10014_020_00378_8
crossref_primary_10_7554_eLife_91313
crossref_primary_10_3390_diagnostics10090648
crossref_primary_10_1038_s41598_023_30395_4
crossref_primary_10_1016_j_ccell_2018_11_015
crossref_primary_10_1186_s40478_024_01798_9
crossref_primary_10_1007_s12253_019_00685_2
crossref_primary_10_1016_j_cell_2020_11_012
crossref_primary_10_1093_neuonc_now013
crossref_primary_10_1038_s42003_019_0420_8
crossref_primary_10_1200_JCO_2014_59_9217
crossref_primary_10_1016_j_cytogfr_2015_11_009
crossref_primary_10_1016_j_molcel_2019_02_029
crossref_primary_10_1111_bpa_12768
crossref_primary_10_1007_s10014_019_00345_y
crossref_primary_10_1111_bpa_12885
crossref_primary_10_1186_s40478_020_0882_4
crossref_primary_10_1186_s40543_020_00219_5
crossref_primary_10_1200_JCO_2017_72_9921
crossref_primary_10_1016_S1470_2045_18_30119_0
crossref_primary_10_3171_2019_2_PEDS18480
crossref_primary_10_1186_s40478_025_01991_4
crossref_primary_10_3390_bioengineering5040088
crossref_primary_10_1186_s41016_020_00218_w
crossref_primary_10_1038_ncomms5846
crossref_primary_10_1016_j_humpath_2025_105769
crossref_primary_10_1038_nrclinonc_2014_74
crossref_primary_10_1158_2159_8290_CD_19_1030
crossref_primary_10_1080_14737159_2017_1266259
crossref_primary_10_1097_PAS_0000000000001690
crossref_primary_10_3389_fnins_2022_986873
crossref_primary_10_1002_jcc_26108
crossref_primary_10_1007_s00401_014_1325_8
crossref_primary_10_1186_s13045_018_0622_4
crossref_primary_10_1002_pbc_25408
crossref_primary_10_3389_fonc_2025_1504803
crossref_primary_10_3389_fonc_2022_891543
crossref_primary_10_1186_s40478_017_0479_8
crossref_primary_10_3390_medicina61030474
crossref_primary_10_1111_bjh_17285
crossref_primary_10_1007_s12017_017_8455_9
crossref_primary_10_1111_febs_15963
crossref_primary_10_1007_s00401_018_1906_z
crossref_primary_10_3389_fonc_2024_1347694
crossref_primary_10_1038_s41467_021_25709_x
crossref_primary_10_1093_neuonc_nou330
crossref_primary_10_1212_CON_0000000000000545
crossref_primary_10_1186_s13619_023_00181_8
crossref_primary_10_3390_cancers13092044
crossref_primary_10_1080_13543776_2016_1217330
crossref_primary_10_1517_13543784_2016_1152261
crossref_primary_10_1038_ng_3141
crossref_primary_10_1016_j_bone_2017_07_024
crossref_primary_10_1007_s00401_020_02155_5
crossref_primary_10_1016_S1470_2045_20_30166_2
crossref_primary_10_1007_s10147_021_02084_7
crossref_primary_10_1016_j_gde_2016_01_003
crossref_primary_10_1097_JCMA_0000000000000358
crossref_primary_10_1634_theoncologist_2017_0614
crossref_primary_10_3389_fped_2023_1193474
crossref_primary_10_3390_cancers17132089
crossref_primary_10_1007_s00401_014_1337_4
crossref_primary_10_3389_fmed_2023_1071447
crossref_primary_10_1007_s00432_021_03813_1
crossref_primary_10_1186_s40170_024_00341_7
crossref_primary_10_1016_j_canlet_2020_08_035
crossref_primary_10_1016_j_biocel_2015_07_006
crossref_primary_10_23907_2017_056
crossref_primary_10_1016_j_neo_2015_12_002
crossref_primary_10_1158_2159_8290_CD_20_1230
crossref_primary_10_3390_ijms21197193
crossref_primary_10_1016_S1634_7072_19_42495_1
crossref_primary_10_1016_j_jocn_2017_10_041
crossref_primary_10_1016_j_bulcan_2016_10_010
crossref_primary_10_1016_j_bbrc_2015_07_148
crossref_primary_10_1016_j_ejca_2025_115629
crossref_primary_10_1016_j_jmoldx_2016_05_005
crossref_primary_10_1016_S1470_2045_14_71206_9
crossref_primary_10_3389_fonc_2021_674596
crossref_primary_10_1517_17460441_2015_1025745
crossref_primary_10_1038_s41379_020_00657_x
crossref_primary_10_3390_brainsci8110200
crossref_primary_10_1016_j_celrep_2024_114829
crossref_primary_10_1146_annurev_cancerbio_070120_102521
crossref_primary_10_1186_s13256_020_02451_4
crossref_primary_10_1002_path_4775
crossref_primary_10_1016_j_pharmthera_2017_08_006
crossref_primary_10_3390_ijms21030753
crossref_primary_10_1158_2159_8290_CD_14_0765
crossref_primary_10_1016_j_tranon_2018_02_020
crossref_primary_10_3390_cancers14030476
crossref_primary_10_1158_0008_5472_CAN_14_1298
crossref_primary_10_1016_j_clim_2017_07_006
crossref_primary_10_1158_2159_8290_CD_20_1201
crossref_primary_10_1186_s40478_022_01381_0
crossref_primary_10_1007_s00381_017_3633_5
crossref_primary_10_1038_s41588_019_0531_7
crossref_primary_10_1038_s41388_023_02705_7
crossref_primary_10_1007_s10014_019_00347_w
crossref_primary_10_1158_1541_7786_MCR_15_0392_T
crossref_primary_10_3390_biomedicines11072002
crossref_primary_10_1038_s41571_020_0384_0
crossref_primary_10_1155_2020_5903863
crossref_primary_10_1038_s41698_017_0033_y
crossref_primary_10_1016_j_molcel_2019_08_030
crossref_primary_10_1016_j_molcel_2022_07_008
crossref_primary_10_1002_jbmr_2848
crossref_primary_10_1158_1078_0432_CCR_24_1063
crossref_primary_10_1016_j_cytogfr_2015_12_007
crossref_primary_10_1007_s10555_019_09824_2
crossref_primary_10_1016_j_apsb_2020_05_004
crossref_primary_10_1093_neuonc_noae021
crossref_primary_10_1200_JCO_18_00573
crossref_primary_10_3389_fonc_2021_679701
crossref_primary_10_1016_j_pbiomolbio_2021_08_002
crossref_primary_10_3390_cancers16051009
crossref_primary_10_1002_ijc_31052
crossref_primary_10_3389_fgene_2018_00397
crossref_primary_10_1007_s00018_017_2714_7
crossref_primary_10_1038_nmeth_3394
crossref_primary_10_1038_s41591_018_0006_x
crossref_primary_10_1002_jcp_27759
crossref_primary_10_1093_annonc_mdz383
crossref_primary_10_3389_fonc_2021_620831
crossref_primary_10_1038_s41379_018_0175_7
crossref_primary_10_1200_JCO_2014_60_1823
crossref_primary_10_1038_s41467_019_12187_5
crossref_primary_10_1016_j_cllc_2018_07_008
crossref_primary_10_3390_cancers11050660
crossref_primary_10_1007_s10555_023_10105_2
crossref_primary_10_1186_s13000_020_01031_w
crossref_primary_10_1007_s00401_016_1539_z
crossref_primary_10_1038_s41392_022_01260_z
crossref_primary_10_1038_s41467_023_37438_4
crossref_primary_10_1097_CCO_0000000000000411
crossref_primary_10_1158_0008_5472_CAN_20_0916
crossref_primary_10_1016_j_neo_2023_100881
crossref_primary_10_1172_JCI154229
crossref_primary_10_1007_s10014_014_0200_6
crossref_primary_10_1016_j_nurpra_2017_08_016
crossref_primary_10_1186_s12885_016_2690_6
crossref_primary_10_1186_s40478_018_0623_0
crossref_primary_10_1007_s11523_018_0590_1
crossref_primary_10_1007_s40272_019_00369_z
crossref_primary_10_1007_s40263_024_01121_z
crossref_primary_10_7554_eLife_31347
crossref_primary_10_1159_000496691
crossref_primary_10_1016_j_neurol_2015_04_002
crossref_primary_10_1016_j_wneu_2017_02_088
crossref_primary_10_1074_jbc_RA117_000321
crossref_primary_10_1007_s13566_018_0344_9
crossref_primary_10_1093_neuonc_noaf064
crossref_primary_10_1158_2159_8290_CD_21_1492
crossref_primary_10_1007_s40336_022_00507_7
crossref_primary_10_1002_path_4442
crossref_primary_10_1093_neuonc_noaf061
crossref_primary_10_1093_neuonc_now209
crossref_primary_10_1038_s41467_019_11661_4
crossref_primary_10_1016_j_stem_2021_02_003
crossref_primary_10_1007_s00412_015_0510_4
crossref_primary_10_1111_nan_12591
crossref_primary_10_3389_fgene_2021_742561
crossref_primary_10_1007_s00401_017_1702_1
crossref_primary_10_1007_s40495_018_0141_6
crossref_primary_10_1371_journal_pone_0118926
crossref_primary_10_1042_BST20160069
crossref_primary_10_1074_jbc_M114_599373
crossref_primary_10_1007_s00401_018_1936_6
crossref_primary_10_1074_jbc_X115_663229
crossref_primary_10_1016_j_gde_2022_101918
crossref_primary_10_1007_s10456_014_9457_y
crossref_primary_10_1016_j_bone_2018_03_015
crossref_primary_10_1038_s41467_021_27889_y
crossref_primary_10_3390_cancers16101814
crossref_primary_10_1146_annurev_cancerbio_030617_050143
crossref_primary_10_1080_14737175_2020_1855144
crossref_primary_10_3390_cancers14184506
crossref_primary_10_1093_neuonc_nou116
crossref_primary_10_24287_1726_1708_2021_20_4_69_77
crossref_primary_10_1146_annurev_genet_120417_031642
crossref_primary_10_1016_j_pathol_2021_05_100
crossref_primary_10_1158_1078_0432_CCR_14_1328
crossref_primary_10_1016_j_mrfmmm_2021_111773
crossref_primary_10_1038_nrc3811
crossref_primary_10_1016_j_ccell_2024_08_006
crossref_primary_10_1016_j_clp_2020_11_003
crossref_primary_10_1371_journal_pone_0169485
crossref_primary_10_1172_JCI142158
crossref_primary_10_12688_f1000research_12833_1
crossref_primary_10_3390_cancers12102937
crossref_primary_10_1007_s00401_021_02382_4
crossref_primary_10_1016_j_semradonc_2014_06_003
crossref_primary_10_1182_blood_2018_05_849554
crossref_primary_10_1016_j_neo_2023_100896
crossref_primary_10_1097_PAS_0000000000002388
crossref_primary_10_1093_neuonc_noaf039
crossref_primary_10_1016_j_neo_2023_100899
crossref_primary_10_1371_journal_pgen_1009225
crossref_primary_10_1093_neuonc_noaf035
crossref_primary_10_1186_s40478_020_00992_9
crossref_primary_10_1007_s00432_018_02836_5
crossref_primary_10_1038_nbt_4017
crossref_primary_10_1007_s00401_018_1912_1
crossref_primary_10_1007_s11060_016_2363_y
crossref_primary_10_1093_brain_awab155
crossref_primary_10_3390_cancers13040758
crossref_primary_10_2217_pgs_14_123
crossref_primary_10_1007_s10014_019_00339_w
crossref_primary_10_1016_j_wneu_2016_07_011
crossref_primary_10_1038_ncomms7044
crossref_primary_10_1002_cjp2_307
crossref_primary_10_1038_nrdp_2015_17
crossref_primary_10_1158_1541_7786_MCR_19_0507
crossref_primary_10_1371_journal_pgen_1005262
crossref_primary_10_3389_fonc_2019_01568
crossref_primary_10_1093_neuonc_noad220
crossref_primary_10_1007_s11427_016_5006_9
crossref_primary_10_1101_gr_211201_116
crossref_primary_10_3390_cancers13215261
crossref_primary_10_1016_j_currproblcancer_2021_100777
crossref_primary_10_1172_JCI96915
crossref_primary_10_1097_MOP_0000000000000172
crossref_primary_10_3171_CASE20112
crossref_primary_10_1016_j_bbcan_2021_188571
crossref_primary_10_1002_pbc_28401
crossref_primary_10_1007_s00381_019_04254_5
crossref_primary_10_1007_s13311_017_0524_0
crossref_primary_10_1016_j_jmoldx_2016_11_005
crossref_primary_10_1093_neuonc_noad105
crossref_primary_10_1177_10668969241239679
crossref_primary_10_1016_j_febslet_2015_04_058
crossref_primary_10_1016_j_ijrobp_2021_09_047
crossref_primary_10_1177_1066896920905888
crossref_primary_10_1093_jnen_nlz011
crossref_primary_10_15252_embj_201796659
crossref_primary_10_1016_j_ejmech_2019_04_053
crossref_primary_10_1186_s13059_023_03122_5
crossref_primary_10_1212_WNL_0000000000207716
crossref_primary_10_3171_2022_3_PEDS2250
crossref_primary_10_3389_fonc_2022_1016343
crossref_primary_10_1007_s11060_020_03655_w
crossref_primary_10_1007_s10014_021_00417_y
crossref_primary_10_2340_1651_226X_2024_26452
crossref_primary_10_3390_diagnostics12092064
crossref_primary_10_1016_j_prp_2019_152572
crossref_primary_10_1038_s41467_021_21081_y
crossref_primary_10_1182_bloodadvances_2021004965
crossref_primary_10_3389_fonc_2017_00057
crossref_primary_10_1016_j_ijrobp_2019_11_020
crossref_primary_10_1080_08880018_2021_1907493
crossref_primary_10_1097_RMR_0000000000000235
crossref_primary_10_3389_fonc_2019_01436
crossref_primary_10_1007_s00401_022_02435_2
crossref_primary_10_1158_1541_7786_MCR_17_0507
crossref_primary_10_3390_ijms18020351
crossref_primary_10_3389_fonc_2016_00180
crossref_primary_10_3390_biomedicines10061311
crossref_primary_10_1093_neuonc_noab299
crossref_primary_10_1186_s40478_020_01107_0
crossref_primary_10_1038_s41374_022_00769_9
crossref_primary_10_1038_s41525_017_0032_5
crossref_primary_10_3390_ijms25158498
crossref_primary_10_1080_13543784_2016_1182497
crossref_primary_10_1111_nan_12432
crossref_primary_10_1007_s00401_020_02142_w
crossref_primary_10_1093_neuonc_noz053
crossref_primary_10_1016_j_pnpbp_2017_05_019
crossref_primary_10_1093_neuonc_noy083
crossref_primary_10_1007_s11418_016_1020_2
crossref_primary_10_1038_s41568_019_0169_x
crossref_primary_10_3389_fonc_2021_806974
crossref_primary_10_3390_diagnostics11040681
crossref_primary_10_3389_fped_2020_556802
crossref_primary_10_1007_s11060_020_03546_0
crossref_primary_10_3390_biomedicines9121875
crossref_primary_10_3390_medicina58101386
crossref_primary_10_1016_j_cell_2024_06_023
crossref_primary_10_1016_j_wneu_2024_05_003
crossref_primary_10_2217_cns_14_37
crossref_primary_10_1038_s41467_019_10043_0
crossref_primary_10_1093_neuonc_noab143
crossref_primary_10_1007_s00292_014_1984_1
crossref_primary_10_1186_s40478_020_00980_z
crossref_primary_10_3389_fonc_2018_00127
crossref_primary_10_1200_JCO_2017_74_2965
crossref_primary_10_1002_pbc_28868
crossref_primary_10_1038_ng_3202
crossref_primary_10_1186_s13148_023_01498_6
crossref_primary_10_3390_diagnostics11040670
crossref_primary_10_1038_celldisc_2016_30
crossref_primary_10_1007_s11940_020_00651_3
crossref_primary_10_1016_j_ejmech_2021_114096
crossref_primary_10_1016_j_neo_2025_101231
crossref_primary_10_1186_s40478_018_0652_8
crossref_primary_10_1111_neup_12370
crossref_primary_10_1016_j_canlet_2024_217154
crossref_primary_10_1016_j_wneu_2024_06_163
crossref_primary_10_1093_neuonc_noab274
crossref_primary_10_2217_cns_14_47
crossref_primary_10_3390_cancers13236099
crossref_primary_10_2217_cns_14_43
crossref_primary_10_1016_j_yamp_2025_05_007
crossref_primary_10_1007_s13311_017_0514_2
crossref_primary_10_1002_pbc_26433
crossref_primary_10_1016_j_ccell_2020_02_002
crossref_primary_10_1093_neuonc_noz057
crossref_primary_10_3892_ol_2016_5024
crossref_primary_10_1016_j_ccell_2017_09_014
crossref_primary_10_1016_j_biopha_2018_08_157
crossref_primary_10_1002_glia_22945
crossref_primary_10_1016_j_cancergen_2021_10_005
crossref_primary_10_1038_s41467_025_61163_9
crossref_primary_10_1016_j_heliyon_2024_e29849
crossref_primary_10_1002_advs_202200353
crossref_primary_10_1016_j_humpath_2021_03_007
crossref_primary_10_1016_j_neo_2017_01_006
crossref_primary_10_1002_ajmg_a_37271
crossref_primary_10_3390_medsci6040085
crossref_primary_10_1007_s00401_017_1771_1
crossref_primary_10_1016_j_neo_2023_100921
crossref_primary_10_1016_j_immuni_2024_09_007
crossref_primary_10_1111_his_13666
crossref_primary_10_1016_j_bmcl_2020_127418
crossref_primary_10_1016_j_mtnano_2023_100347
crossref_primary_10_1007_s10147_024_02522_2
crossref_primary_10_1016_j_cancergen_2020_02_004
crossref_primary_10_1155_2018_4596812
crossref_primary_10_1038_s43018_022_00408_8
crossref_primary_10_3390_cells8080913
crossref_primary_10_1038_s41467_021_24168_8
crossref_primary_10_1016_j_ccell_2020_03_011
crossref_primary_10_3389_fonc_2018_00191
crossref_primary_10_1038_s41568_020_00330_0
crossref_primary_10_1177_17588359221113693
crossref_primary_10_1007_s00381_023_06095_9
crossref_primary_10_3390_cancers13051147
crossref_primary_10_1007_s00381_022_05506_7
crossref_primary_10_1016_j_molonc_2014_06_001
crossref_primary_10_1016_j_ijrobp_2022_01_054
crossref_primary_10_1007_s13402_024_01033_6
crossref_primary_10_14814_phy2_14567
crossref_primary_10_3389_fped_2022_910268
crossref_primary_10_1016_j_cancergen_2015_04_008
crossref_primary_10_1186_s40478_020_00902_z
crossref_primary_10_1002_kjm2_12824
crossref_primary_10_1007_s00381_019_04372_0
crossref_primary_10_1016_j_jconrel_2024_05_018
crossref_primary_10_1038_s41591_018_0086_7
crossref_primary_10_1111_cns_14225
crossref_primary_10_24287_1726_1708_2019_18_4_109_117
crossref_primary_10_1038_s41467_020_16786_5
crossref_primary_10_1038_s41467_024_52973_4
crossref_primary_10_1182_blood_2019003691
crossref_primary_10_1080_14789450_2019_1575206
crossref_primary_10_3390_cancers13051114
crossref_primary_10_1038_ncomms10148
crossref_primary_10_1177_0883073815604221
crossref_primary_10_1016_j_bone_2017_08_001
crossref_primary_10_1007_s00292_020_00864_y
crossref_primary_10_1007_s00401_015_1405_4
crossref_primary_10_1093_neuonc_noad003
crossref_primary_10_1212_01_CON_0000464176_96311_d1
crossref_primary_10_1158_0008_5472_CAN_17_3691
crossref_primary_10_1007_s11910_015_0532_6
crossref_primary_10_1158_0008_5472_CAN_15_2157
crossref_primary_10_1007_s11910_017_0722_5
crossref_primary_10_1038_s41698_018_0072_z
crossref_primary_10_1007_s10072_018_3407_1
crossref_primary_10_1038_s41572_024_00516_y
crossref_primary_10_1007_s10014_017_0287_7
crossref_primary_10_1016_j_jmoldx_2019_03_008
crossref_primary_10_3390_cancers13061278
crossref_primary_10_3390_cells8111366
crossref_primary_10_1007_s00401_014_1338_3
crossref_primary_10_1007_s11060_019_03271_3
crossref_primary_10_1126_sciadv_1501354
crossref_primary_10_3390_genes11030287
crossref_primary_10_1007_s00018_016_2221_2
crossref_primary_10_1093_jnen_nly022
crossref_primary_10_1002_gcc_23180
crossref_primary_10_1016_j_ccell_2017_08_017
crossref_primary_10_1016_j_jmoldx_2023_09_002
crossref_primary_10_1016_j_neo_2023_100931
crossref_primary_10_1016_j_omto_2023_08_005
crossref_primary_10_1038_s41416_025_02961_2
crossref_primary_10_1093_neuonc_noad130
crossref_primary_10_1016_j_cppeds_2016_04_004
crossref_primary_10_3390_pharmaceutics14091762
crossref_primary_10_1038_onc_2015_172
crossref_primary_10_17650_2222_1468_2024_14_1_49_55
crossref_primary_10_3389_fonc_2025_1587157
crossref_primary_10_1016_j_nec_2020_12_001
crossref_primary_10_1016_j_wneu_2017_02_026
crossref_primary_10_1093_neuros_nyx507
crossref_primary_10_1186_s41016_015_0006_3
crossref_primary_10_1200_EDBK_25_473324
crossref_primary_10_1002_pbc_26751
crossref_primary_10_1056_NEJMoa1508054
crossref_primary_10_1186_s43556_022_00110_2
crossref_primary_10_3390_genes8040107
crossref_primary_10_1016_j_lpm_2018_04_015
Cites_doi 10.1016/j.cell.2013.02.023
10.1016/j.ccr.2013.10.006
10.1101/gr.8.3.195
10.1074/jbc.M113.475301
10.1158/0008-5472.CAN-09-1851
10.1101/gad.217778.113
10.1083/jcb.201210031
10.1002/dneu.22022
10.1038/ng1783
10.1038/nature11329
10.1200/JCO.2006.07.8626
10.1016/j.cell.2012.08.026
10.1038/onc.2011.121
10.1007/s00401-012-1070-9
10.1093/neuonc/noq158
10.1200/JCO.2009.26.7252
10.1038/ng.2734
10.1006/geno.1995.1100
10.1016/j.ccr.2007.12.005
10.1074/jbc.M112.365932
10.1093/neuonc/nop001
10.1371/journal.pone.0030313
10.1111/bpa.12042
10.1016/j.cell.2012.08.033
10.1080/01621459.1984.10477105
10.1111/j.1476-5381.2010.00871.x
10.1158/1078-0432.CCR-08-0651
10.1007/s00401-012-0998-0
10.1038/nature05349
10.1016/j.ccr.2012.08.024
10.1101/gad.1636408
10.1007/s00401-013-1095-8
10.1038/nature10833
10.1007/s11914-011-0046-3
10.1038/nature10725
10.1038/nature11213
10.1073/pnas.1303607110
10.1126/science.1164382
10.1128/MCB.00099-07
10.1016/j.semcancer.2005.01.003
10.1038/ng.2735
10.1038/ng.1102
10.1038/nature11284
10.1016/j.ccr.2011.12.023
10.1158/0008-5472.CAN-10-3597
10.1128/MCB.22.14.5100-5113.2002
10.1182/blood.V93.2.488.402k17_488_499
10.1038/ng747
10.1200/JCO.2009.25.5463
10.1158/1078-0432.CCR-08-3210
10.1126/science.1232245
10.1016/j.ccr.2007.11.012
10.1093/bioinformatics/btp324
10.1038/nbt957
10.1177/0883073808321765
10.1007/s11060-012-0842-3
10.1200/JCO.2011.35.5677
10.1128/MCB.01595-12
10.1038/nature10733
10.1158/1078-0432.CCR-10-0438
10.1016/j.cell.2010.11.055
10.1038/ng.2682
10.1158/0008-5472.CAN-04-2487
10.1371/journal.pcbi.0010053
10.1038/ng.2532
10.1038/nmeth.1628
10.1182/blood.V93.4.1355
10.1002/dneu.20769
10.1038/nature07385
ContentType Journal Article
Copyright Springer Nature America, Inc. 2014
COPYRIGHT 2014 Nature Publishing Group
Copyright Nature Publishing Group May 2014
Copyright_xml – notice: Springer Nature America, Inc. 2014
– notice: COPYRIGHT 2014 Nature Publishing Group
– notice: Copyright Nature Publishing Group May 2014
CorporateAuthor the St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project
CorporateAuthor_xml – name: the St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QL
7QP
7QR
7SS
7T7
7TK
7TM
7U9
7X7
7XB
88A
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7N
M7P
MBDVC
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
5PM
DOI 10.1038/ng.2938
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Entomology Abstracts (Full archive)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni Edition)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Research Library Prep

MEDLINE
Genetics Abstracts

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Agriculture
Biology
EISSN 1546-1718
EndPage 450
ExternalDocumentID PMC4056452
3304445751
A368073409
24705251
10_1038_ng_2938
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: P30 CA021765
– fundername: NCI NIH HHS
  grantid: R01 CA135554
– fundername: NCI NIH HHS
  grantid: P01 CA096832
– fundername: NCI NIH HHS
  grantid: P30 CA016056
GroupedDBID ---
-DZ
-~X
.55
.GJ
0R~
123
29M
2FS
36B
39C
3O-
3V.
4.4
53G
5BI
5M7
5RE
5S5
70F
7X7
85S
88A
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AAEEF
AAHBH
AARCD
AAYOK
AAYZH
AAZLF
ABAWZ
ABCQX
ABDBF
ABDPE
ABEFU
ABJNI
ABLJU
ABOCM
ABTAH
ABUWG
ACBWK
ACGFO
ACGFS
ACIWK
ACMJI
ACNCT
ACPRK
ACUHS
ADBBV
ADFRT
AENEX
AEUYN
AFBBN
AFFNX
AFKRA
AFRAH
AFSHS
AGAYW
AGCDD
AGHTU
AHBCP
AHMBA
AHOSX
AHSBF
AIBTJ
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
ARMCB
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B0M
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CCPQU
CS3
DB5
DU5
DWQXO
EAD
EAP
EBC
EBD
EBS
EE.
EJD
EMB
EMK
EMOBN
EPL
ESX
EXGXG
F5P
FEDTE
FQGFK
FSGXE
FYUFA
GNUQQ
GUQSH
GX1
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IH2
IHR
INH
INR
IOV
ISR
ITC
L7B
LGEZI
LK8
LOTEE
M0L
M1P
M2O
M7P
MVM
N9A
NADUK
NNMJJ
NXXTH
ODYON
P2P
PKN
PQQKQ
PROAC
PSQYO
Q2X
RIG
RNS
RNT
RNTTT
RVV
SHXYY
SIXXV
SJN
SNYQT
SOJ
SV3
TAOOD
TBHMF
TDRGL
TN5
TSG
TUS
UKHRP
VQA
X7M
XJT
XOL
Y6R
YHZ
ZGI
ZXP
ZY4
~8M
~KM
AAYXX
ABFSG
ACSTC
AETEA
AFANA
AFFHD
AIEIU
ALPWD
ATHPR
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7QR
7SS
7T7
7TK
7TM
7U9
7XB
8FD
8FK
C1K
FR3
H94
K9.
M7N
MBDVC
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
RC3
7X8
5PM
ID FETCH-LOGICAL-c664t-ac8eb6ebb3a8f99a17cecacf510d026e563ac01122b5240f0b5e6f73c3dc67173
IEDL.DBID M7P
ISICitedReferencesCount 827
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000335422900009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1061-4036
1546-1718
IngestDate Tue Nov 04 01:58:02 EST 2025
Sun Nov 09 10:55:34 EST 2025
Sun Nov 09 09:55:03 EST 2025
Fri Oct 03 11:11:36 EDT 2025
Sat Nov 29 13:22:00 EST 2025
Sun Nov 23 09:02:38 EST 2025
Wed Nov 26 09:52:10 EST 2025
Wed Nov 26 10:13:34 EST 2025
Wed Feb 19 02:40:32 EST 2025
Tue Nov 18 20:53:19 EST 2025
Sat Nov 29 03:07:06 EST 2025
Fri Feb 21 02:37:41 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License http://www.springer.com/tdm
Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c664t-ac8eb6ebb3a8f99a17cecacf510d026e563ac01122b5240f0b5e6f73c3dc67173
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC4056452
PMID 24705251
PQID 1524713280
PQPubID 33429
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4056452
proquest_miscellaneous_1554952022
proquest_miscellaneous_1519842540
proquest_journals_1524713280
gale_infotracmisc_A368073409
gale_infotracacademiconefile_A368073409
gale_incontextgauss_ISR_A368073409
gale_incontextgauss_IOV_A368073409
pubmed_primary_24705251
crossref_citationtrail_10_1038_ng_2938
crossref_primary_10_1038_ng_2938
springer_journals_10_1038_ng_2938
PublicationCentury 2000
PublicationDate 2014-05-01
PublicationDateYYYYMMDD 2014-05-01
PublicationDate_xml – month: 05
  year: 2014
  text: 2014-05-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationTitle Nature genetics
PublicationTitleAbbrev Nat Genet
PublicationTitleAlternate Nat Genet
PublicationYear 2014
Publisher Nature Publishing Group US
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group US
– name: Nature Publishing Group
References Rousseeuw (CR62) 1984; 79
Zhao, Ayrault, Zindy, Kim, Roussel (CR25) 2008; 22
Robinson (CR47) 2012; 488
Li (CR39) 2012; 108
Frattini (CR32) 2013; 45
Venneti (CR43) 2013; 23
Paugh (CR8) 2011; 29
Stephens (CR53) 2011; 144
Schwartzentruber (CR3) 2012; 482
Shen (CR22) 2009; 119
Zhang (CR57) 2012; 481
Kawauchi (CR65) 2012; 21
Lannon, Sorensen (CR33) 2005; 15
Chaikuad (CR20) 2012; 287
Wu (CR4) 2012; 44
Puget (CR11) 2012; 7
Sturm (CR17) 2012; 22
Cetinbas (CR37) 2013; 288
Thiele, Li, McKee (CR29) 2009; 15
Pugh (CR50) 2012; 488
Torchia, Boyd, Rehg, Qu, Baker (CR56) 2007; 27
Endersby, Zhu, Hay, Ellison, Baker (CR70) 2011; 71
Jones (CR49) 2012; 488
Shore (CR19) 2006; 38
Piccirillo (CR26) 2006; 444
Cannon, Upton, Smith, Morrell (CR23) 2010; 161
Dubuc (CR48) 2013; 125
Wang (CR58) 2011; 8
Kleiblova (CR55) 2013; 201
Paugh (CR9) 2010; 28
Persons (CR66) 1999; 93
Pollack (CR2) 2001; 61
Holmfeldt (CR63) 2013; 45
Gottardo, Gajjar (CR1) 2008; 23
Faury (CR6) 2007; 25
Zhang (CR30) 2013; 45
Bax (CR15) 2010; 16
Lewis (CR42) 2013; 340
Barrow (CR16) 2011; 13
Füllgrabe, Kavanagh, Joseph (CR45) 2011; 30
Zhang (CR60) 2005; 1
Lin (CR52) 2012; 151
Fontebasso (CR40) 2013; 125
CR14
Schiffman (CR10) 2010; 70
Jones (CR31) 2013; 45
Qu (CR7) 2010; 12
Butti (CR36) 1995; 28
Bender (CR44) 2013; 24
Zarghooni (CR12) 2010; 28
Szymczak (CR64) 2004; 22
Chan (CR41) 2013; 27
Korbel, Campbell (CR71) 2013; 152
Bajenaru (CR67) 2002; 22
Nie (CR51) 2012; 151
Zhang (CR46) 2012; 481
Killela (CR54) 2013; 110
Fraser (CR69) 2004; 64
Gordon, Abajian, Green (CR61) 1998; 8
Li, Durbin (CR59) 2009; 25
Li (CR34) 2007; 12
Parsons (CR13) 2008; 321
Shore, Kaplan (CR18) 2011; 9
Bond, Bhalala, Kessler (CR24) 2012; 72
Bagarova (CR21) 2013; 33
Harel, Costa, Fainzilber (CR28) 2010; 70
Lee (CR27) 2008; 13
Bax (CR38) 2009; 15
Jonkers (CR68) 2001; 29
Eguchi (CR35) 1999; 93
Khuong-Quang (CR5) 2012; 124
DA Khuong-Quang (BFng2938_CR5) 2012; 124
JE Cannon (BFng2938_CR23) 2010; 161
P Rousseeuw (BFng2938_CR62) 1984; 79
SG Piccirillo (BFng2938_CR26) 2006; 444
N Cetinbas (BFng2938_CR37) 2013; 288
A Chaikuad (BFng2938_CR20) 2012; 287
J Zhang (BFng2938_CR60) 2005; 1
D Sturm (BFng2938_CR17) 2012; 22
G Li (BFng2938_CR39) 2012; 108
DA Bax (BFng2938_CR38) 2009; 15
PJ Killela (BFng2938_CR54) 2013; 110
J Wang (BFng2938_CR58) 2011; 8
DW Parsons (BFng2938_CR13) 2008; 321
HQ Qu (BFng2938_CR7) 2010; 12
M Zarghooni (BFng2938_CR12) 2010; 28
JO Korbel (BFng2938_CR71) 2013; 152
L Holmfeldt (BFng2938_CR63) 2013; 45
R Endersby (BFng2938_CR70) 2011; 71
Q Shen (BFng2938_CR22) 2009; 119
DA Bax (BFng2938_CR15) 2010; 16
J Füllgrabe (BFng2938_CR45) 2011; 30
PW Lewis (BFng2938_CR42) 2013; 340
DA Persons (BFng2938_CR66) 1999; 93
TJ Pugh (BFng2938_CR50) 2012; 488
BFng2938_CR14
Z Nie (BFng2938_CR51) 2012; 151
J Zhang (BFng2938_CR46) 2012; 481
P Kleiblova (BFng2938_CR55) 2013; 201
S Bender (BFng2938_CR44) 2013; 24
S Venneti (BFng2938_CR43) 2013; 23
AM Fontebasso (BFng2938_CR40) 2013; 125
D Kawauchi (BFng2938_CR65) 2012; 21
G Wu (BFng2938_CR4) 2012; 44
MM Fraser (BFng2938_CR69) 2004; 64
CL Lannon (BFng2938_CR33) 2005; 15
D Gordon (BFng2938_CR61) 1998; 8
DT Jones (BFng2938_CR49) 2012; 488
D Faury (BFng2938_CR6) 2007; 25
V Frattini (BFng2938_CR32) 2013; 45
J Barrow (BFng2938_CR16) 2011; 13
MG Butti (BFng2938_CR36) 1995; 28
JD Schiffman (BFng2938_CR10) 2010; 70
J Zhang (BFng2938_CR30) 2013; 45
ML Bajenaru (BFng2938_CR67) 2002; 22
CY Lin (BFng2938_CR52) 2012; 151
S Puget (BFng2938_CR11) 2012; 7
M Eguchi (BFng2938_CR35) 1999; 93
AM Dubuc (BFng2938_CR48) 2013; 125
EM Shore (BFng2938_CR19) 2006; 38
NG Gottardo (BFng2938_CR1) 2008; 23
H Zhao (BFng2938_CR25) 2008; 22
PJ Stephens (BFng2938_CR53) 2011; 144
EM Shore (BFng2938_CR18) 2011; 9
BS Paugh (BFng2938_CR9) 2010; 28
J Zhang (BFng2938_CR57) 2012; 481
J Lee (BFng2938_CR27) 2008; 13
AM Bond (BFng2938_CR24) 2012; 72
J Schwartzentruber (BFng2938_CR3) 2012; 482
BS Paugh (BFng2938_CR8) 2011; 29
CJ Thiele (BFng2938_CR29) 2009; 15
G Robinson (BFng2938_CR47) 2012; 488
J Jonkers (BFng2938_CR68) 2001; 29
KM Chan (BFng2938_CR41) 2013; 27
EC Torchia (BFng2938_CR56) 2007; 27
IF Pollack (BFng2938_CR2) 2001; 61
J Bagarova (BFng2938_CR21) 2013; 33
Z Li (BFng2938_CR34) 2007; 12
L Harel (BFng2938_CR28) 2010; 70
AL Szymczak (BFng2938_CR64) 2004; 22
H Li (BFng2938_CR59) 2009; 25
DT Jones (BFng2938_CR31) 2013; 45
22237106 - Nature. 2012 Jan 12;481(7380):157-63
23817572 - Nat Genet. 2013 Aug;45(8):927-32
23649806 - J Cell Biol. 2013 May 13;201(4):511-21
11606370 - Cancer Res. 2001 Oct 15;61(20):7404-7
22237022 - Nature. 2012 Jan 19;481(7381):329-34
12077339 - Mol Cell Biol. 2002 Jul;22(14):5100-13
9521923 - Genome Res. 1998 Mar;8(3):195-202
9885210 - Blood. 1999 Jan 15;93(2):488-99
24183680 - Cancer Cell. 2013 Nov 11;24(5):660-72
21516126 - Oncogene. 2011 Aug 4;30(31):3391-403
20186708 - Dev Neurobiol. 2010 Apr;70(5):298-303
20479398 - J Clin Oncol. 2010 Jun 20;28(18):3061-8
23798677 - J Biol Chem. 2013 Sep 27;288(39):27940-50
23539183 - Science. 2013 May 17;340(6134):857-61
15826836 - Semin Cancer Biol. 2005 Jun;15(3):215-23
22389665 - PLoS One. 2012;7(2):e30313
22820256 - Nature. 2012 Aug 2;488(7409):106-10
21138945 - Neuro Oncol. 2011 Feb;13(2):212-22
16261194 - PLoS Comput Biol. 2005 Oct;1(5):e53
20718746 - Br J Pharmacol. 2010 Sep;161(1):140-9
23917401 - Nat Genet. 2013 Oct;45(10):1141-9
18167341 - Cancer Cell. 2008 Jan;13(1):69-80
19855136 - J Clin Invest. 2009 Nov;119(11):3462-72
21340697 - Curr Osteoporos Rep. 2011 Jun;9(2):83-8
24769718 - Nat Genet. 2014 May;46(5):421-2
23498933 - Cell. 2013 Mar 14;152(6):1226-36
11694875 - Nat Genet. 2001 Dec;29(4):418-25
17875932 - Mol Cell Biol. 2007 Nov;27(22):7918-34
22977237 - J Biol Chem. 2012 Oct 26;287(44):36990-8
23572558 - Mol Cell Biol. 2013 Jun;33(12):2413-24
22340591 - Cancer Cell. 2012 Feb 14;21(2):168-80
21931021 - J Clin Oncol. 2011 Oct 20;29(30):3999-4006
23021216 - Cell. 2012 Sep 28;151(1):68-79
23334668 - Nat Genet. 2013 Mar;45(3):242-52
15520182 - Cancer Res. 2004 Nov 1;64(21):7773-9
21666668 - Nat Methods. 2011 Aug;8(8):652-4
19451168 - Bioinformatics. 2009 Jul 15;25(14):1754-60
20570930 - Clin Cancer Res. 2010 Jul 1;16(13):3368-77
15064769 - Nat Biotechnol. 2004 May;22(5):589-94
23079654 - Cancer Cell. 2012 Oct 16;22(4):425-37
21215367 - Cell. 2011 Jan 7;144(1):27-40
23530248 - Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6021-6
18772396 - Science. 2008 Sep 26;321(5897):1807-12
19737945 - Clin Cancer Res. 2009 Sep 15;15(18):5753-61
19755385 - Clin Cancer Res. 2009 Oct 1;15(19):5962-7
18952581 - J Child Neurol. 2008 Oct;23(10):1149-59
23414300 - Brain Pathol. 2013 Sep;23(5):558-64
22489086 - Dev Neurobiol. 2012 Jul;72(7):1068-84
7590742 - Genomics. 1995 Jul 1;28(1):15-24
22722829 - Nature. 2012 Aug 2;488(7409):43-8
22382786 - J Neurooncol. 2012 Jul;108(3):395-402
22832583 - Nature. 2012 Aug 2;488(7409):100-5
17401009 - J Clin Oncol. 2007 Apr 1;25(10):1196-208
22286061 - Nature. 2012 Feb 9;482(7384):226-31
17151667 - Nature. 2006 Dec 7;444(7120):761-5
18068631 - Cancer Cell. 2007 Dec;12(6):542-58
18772890 - Nature. 2008 Oct 23;455(7216):1061-8
22286216 - Nat Genet. 2012 Mar;44(3):251-3
23603901 - Genes Dev. 2013 May 1;27(9):985-90
23021215 - Cell. 2012 Sep 28;151(1):56-67
21507933 - Cancer Res. 2011 Jun 15;71(12):4106-16
23417712 - Acta Neuropathol. 2013 May;125(5):659-69
20150382 - Neuro Oncol. 2010 Feb;12(2):153-63
20142589 - J Clin Oncol. 2010 Mar 10;28(8):1337-44
23184418 - Acta Neuropathol. 2013 Mar;125(3):373-84
18347090 - Genes Dev. 2008 Mar 15;22(6):722-7
20068183 - Cancer Res. 2010 Jan 15;70(2):512-9
22661320 - Acta Neuropathol. 2012 Sep;124(3):439-47
24840074 - Nat Rev Clin Oncol. 2014 Jun;11(6):300
16642017 - Nat Genet. 2006 May;38(5):525-7
23583981 - Nat Genet. 2013 Jun;45(6):602-12
9949179 - Blood. 1999 Feb 15;93(4):1355-63
References_xml – volume: 70
  start-page: 298
  year: 2010
  end-page: 303
  ident: CR28
  article-title: On the death Trk
  publication-title: Dev. Neurobiol.
– volume: 152
  start-page: 1226
  year: 2013
  end-page: 1236
  ident: CR71
  article-title: Criteria for inference of chromothripsis in cancer genomes
  publication-title: Cell
  doi: 10.1016/j.cell.2013.02.023
– volume: 24
  start-page: 660
  year: 2013
  end-page: 672
  ident: CR44
  article-title: Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2013.10.006
– volume: 8
  start-page: 195
  year: 1998
  end-page: 202
  ident: CR61
  article-title: Consed: a graphical tool for sequence finishing
  publication-title: Genome Res.
  doi: 10.1101/gr.8.3.195
– volume: 119
  start-page: 3462
  year: 2009
  end-page: 3472
  ident: CR22
  article-title: The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization
  publication-title: J. Clin. Invest.
– volume: 288
  start-page: 27940
  year: 2013
  end-page: 27950
  ident: CR37
  article-title: Mutation of the salt bridge–forming residues in the ETV6 SAM domain interface blocks ETV6-NTRK3 induced cellular transformation
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M113.475301
– volume: 70
  start-page: 512
  year: 2010
  end-page: 519
  ident: CR10
  article-title: Oncogenic mutation with inactivation is characteristic of a subset of pediatric malignant astrocytomas
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-09-1851
– volume: 27
  start-page: 985
  year: 2013
  end-page: 990
  ident: CR41
  article-title: The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
  publication-title: Genes Dev.
  doi: 10.1101/gad.217778.113
– volume: 201
  start-page: 511
  year: 2013
  end-page: 521
  ident: CR55
  article-title: Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint
  publication-title: J. Cell Biol.
  doi: 10.1083/jcb.201210031
– volume: 72
  start-page: 1068
  year: 2012
  end-page: 1084
  ident: CR24
  article-title: The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturation
  publication-title: Dev. Neurobiol.
  doi: 10.1002/dneu.22022
– volume: 38
  start-page: 525
  year: 2006
  end-page: 527
  ident: CR19
  article-title: A recurrent mutation in the BMP type I receptor causes inherited and sporadic fibrodysplasia ossificans progressiva
  publication-title: Nat. Genet.
  doi: 10.1038/ng1783
– volume: 488
  start-page: 106
  year: 2012
  end-page: 110
  ident: CR50
  article-title: Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
  publication-title: Nature
  doi: 10.1038/nature11329
– volume: 25
  start-page: 1196
  year: 2007
  end-page: 1208
  ident: CR6
  article-title: Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2006.07.8626
– volume: 151
  start-page: 56
  year: 2012
  end-page: 67
  ident: CR52
  article-title: Transcriptional amplification in tumor cells with elevated c-Myc
  publication-title: Cell
  doi: 10.1016/j.cell.2012.08.026
– volume: 30
  start-page: 3391
  year: 2011
  end-page: 3403
  ident: CR45
  article-title: Histone onco-modifications
  publication-title: Oncogene
  doi: 10.1038/onc.2011.121
– volume: 125
  start-page: 373
  year: 2013
  end-page: 384
  ident: CR48
  article-title: Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-012-1070-9
– volume: 13
  start-page: 212
  year: 2011
  end-page: 222
  ident: CR16
  article-title: Homozygous loss of revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas
  publication-title: Neuro-oncol.
  doi: 10.1093/neuonc/noq158
– volume: 28
  start-page: 3061
  year: 2010
  end-page: 3068
  ident: CR9
  article-title: Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2009.26.7252
– volume: 45
  start-page: 1141
  year: 2013
  end-page: 1149
  ident: CR32
  article-title: The integrated landscape of driver genomic alterations in glioblastoma
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2734
– volume: 28
  start-page: 15
  year: 1995
  end-page: 24
  ident: CR36
  article-title: A sequence analysis of the genomic regions involved in the rearrangements between and genes producing oncogenes in papillary thyroid carcinomas
  publication-title: Genomics
  doi: 10.1006/geno.1995.1100
– volume: 61
  start-page: 7404
  year: 2001
  end-page: 7407
  ident: CR2
  article-title: Age and mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort
  publication-title: Cancer Res.
– volume: 13
  start-page: 69
  year: 2008
  end-page: 80
  ident: CR27
  article-title: Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.12.005
– volume: 287
  start-page: 36990
  year: 2012
  end-page: 36998
  ident: CR20
  article-title: Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M112.365932
– volume: 12
  start-page: 153
  year: 2010
  end-page: 163
  ident: CR7
  article-title: Genome-wide profiling using single-nucleotide polymorphism arrays identifies novel chromosomal imbalances in pediatric glioblastomas
  publication-title: Neuro-oncol.
  doi: 10.1093/neuonc/nop001
– volume: 7
  start-page: e30313
  year: 2012
  ident: CR11
  article-title: Mesenchymal transition and amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0030313
– volume: 23
  start-page: 558
  year: 2013
  end-page: 564
  ident: CR43
  article-title: Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas
  publication-title: Brain Pathol.
  doi: 10.1111/bpa.12042
– volume: 151
  start-page: 68
  year: 2012
  end-page: 79
  ident: CR51
  article-title: c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells
  publication-title: Cell
  doi: 10.1016/j.cell.2012.08.033
– volume: 79
  start-page: 871
  year: 1984
  end-page: 880
  ident: CR62
  article-title: Least Median Squares Regression
  publication-title: J. Am. Stat. Assoc.
  doi: 10.1080/01621459.1984.10477105
– volume: 161
  start-page: 140
  year: 2010
  end-page: 149
  ident: CR23
  article-title: Intersegmental vessel formation in zebrafish: requirement for VEGF but not BMP signalling revealed by selective and non-selective BMP antagonists
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/j.1476-5381.2010.00871.x
– volume: 15
  start-page: 5962
  year: 2009
  end-page: 5967
  ident: CR29
  article-title: On Trk—the TrkB signal transduction pathway is an increasingly important target in cancer biology
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-08-0651
– volume: 93
  start-page: 1355
  year: 1999
  end-page: 1363
  ident: CR35
  article-title: Fusion of to neurotrophin-3 receptor in acute myeloid leukemia with t(12;15)(p13;q25)
  publication-title: Blood
– volume: 124
  start-page: 439
  year: 2012
  end-page: 447
  ident: CR5
  article-title: K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-012-0998-0
– volume: 444
  start-page: 761
  year: 2006
  end-page: 765
  ident: CR26
  article-title: Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour–initiating cells
  publication-title: Nature
  doi: 10.1038/nature05349
– volume: 22
  start-page: 425
  year: 2012
  end-page: 437
  ident: CR17
  article-title: Hotspot mutations in and define distinct epigenetic and biological subgroups of glioblastoma
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.08.024
– volume: 22
  start-page: 722
  year: 2008
  end-page: 727
  ident: CR25
  article-title: Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development
  publication-title: Genes Dev.
  doi: 10.1101/gad.1636408
– volume: 125
  start-page: 659
  year: 2013
  end-page: 669
  ident: CR40
  article-title: Mutations in and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-013-1095-8
– volume: 482
  start-page: 226
  year: 2012
  end-page: 231
  ident: CR3
  article-title: Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
  publication-title: Nature
  doi: 10.1038/nature10833
– volume: 9
  start-page: 83
  year: 2011
  end-page: 88
  ident: CR18
  article-title: Role of altered signal transduction in heterotopic ossification and fibrodysplasia ossificans progressiva
  publication-title: Curr. Osteoporos. Rep.
  doi: 10.1007/s11914-011-0046-3
– volume: 481
  start-page: 157
  year: 2012
  end-page: 163
  ident: CR46
  article-title: The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
  publication-title: Nature
  doi: 10.1038/nature10725
– volume: 488
  start-page: 43
  year: 2012
  end-page: 48
  ident: CR47
  article-title: Novel mutations target distinct subgroups of medulloblastoma
  publication-title: Nature
  doi: 10.1038/nature11213
– ident: CR14
– volume: 110
  start-page: 6021
  year: 2013
  end-page: 6026
  ident: CR54
  article-title: promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1303607110
– volume: 321
  start-page: 1807
  year: 2008
  end-page: 1812
  ident: CR13
  article-title: An integrated genomic analysis of human glioblastoma multiforme
  publication-title: Science
  doi: 10.1126/science.1164382
– volume: 27
  start-page: 7918
  year: 2007
  end-page: 7934
  ident: CR56
  article-title: EWS/FLI-1 induces rapid onset of myeloid/erythroid leukemia in mice
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.00099-07
– volume: 15
  start-page: 215
  year: 2005
  end-page: 223
  ident: CR33
  article-title: ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2005.01.003
– volume: 45
  start-page: 602
  year: 2013
  end-page: 612
  ident: CR30
  article-title: Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2735
– volume: 44
  start-page: 251
  year: 2012
  end-page: 253
  ident: CR4
  article-title: Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
  publication-title: Nat. Genet.
  doi: 10.1038/ng.1102
– volume: 488
  start-page: 100
  year: 2012
  end-page: 105
  ident: CR49
  article-title: Dissecting the genomic complexity underlying medulloblastoma
  publication-title: Nature
  doi: 10.1038/nature11284
– volume: 21
  start-page: 168
  year: 2012
  end-page: 180
  ident: CR65
  article-title: A mouse model of the most aggressive subgroup of human medulloblastoma
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2011.12.023
– volume: 71
  start-page: 4106
  year: 2011
  end-page: 4116
  ident: CR70
  article-title: Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-10-3597
– volume: 22
  start-page: 5100
  year: 2002
  end-page: 5113
  ident: CR67
  article-title: Astrocyte-specific inactivation of the neurofibromatosis 1 gene ( ) is insufficient for astrocytoma formation
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.22.14.5100-5113.2002
– volume: 93
  start-page: 488
  year: 1999
  end-page: 499
  ident: CR66
  article-title: Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis
  publication-title: Blood
  doi: 10.1182/blood.V93.2.488.402k17_488_499
– volume: 29
  start-page: 418
  year: 2001
  end-page: 425
  ident: CR68
  article-title: Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
  publication-title: Nat. Genet.
  doi: 10.1038/ng747
– volume: 28
  start-page: 1337
  year: 2010
  end-page: 1344
  ident: CR12
  article-title: Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor α and poly (ADP-ribose) polymerase as potential therapeutic targets
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2009.25.5463
– volume: 15
  start-page: 5753
  year: 2009
  end-page: 5761
  ident: CR38
  article-title: EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-08-3210
– volume: 340
  start-page: 857
  year: 2013
  end-page: 861
  ident: CR42
  article-title: Inhibition of PRC2 activity by a gain-of-function H3 H3 mutation found in pediatric glioblastoma
  publication-title: Science
  doi: 10.1126/science.1232245
– volume: 12
  start-page: 542
  year: 2007
  end-page: 558
  ident: CR34
  article-title: - fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.11.012
– volume: 25
  start-page: 1754
  year: 2009
  end-page: 1760
  ident: CR59
  article-title: Fast and accurate short read alignment with Burrows-Wheeler transform
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp324
– volume: 22
  start-page: 589
  year: 2004
  end-page: 594
  ident: CR64
  article-title: Correction of multi-gene deficiency using a single 'self-cleaving' 2A peptide–based retroviral vector
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt957
– volume: 23
  start-page: 1149
  year: 2008
  end-page: 1159
  ident: CR1
  article-title: Chemotherapy for malignant brain tumors of childhood
  publication-title: J. Child Neurol.
  doi: 10.1177/0883073808321765
– volume: 108
  start-page: 395
  year: 2012
  end-page: 402
  ident: CR39
  article-title: Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas
  publication-title: J. Neurooncol.
  doi: 10.1007/s11060-012-0842-3
– volume: 29
  start-page: 3999
  year: 2011
  end-page: 4006
  ident: CR8
  article-title: Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2011.35.5677
– volume: 33
  start-page: 2413
  year: 2013
  end-page: 2424
  ident: CR21
  article-title: Constitutively active ALK2 receptor mutants require type II receptor cooperation
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.01595-12
– volume: 481
  start-page: 329
  year: 2012
  end-page: 334
  ident: CR57
  article-title: A novel retinoblastoma therapy from genomic and epigenetic analyses
  publication-title: Nature
  doi: 10.1038/nature10733
– volume: 16
  start-page: 3368
  year: 2010
  end-page: 3377
  ident: CR15
  article-title: A distinct spectrum of copy number aberrations in pediatric high-grade gliomas
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-10-0438
– volume: 144
  start-page: 27
  year: 2011
  end-page: 40
  ident: CR53
  article-title: Massive genomic rearrangement acquired in a single catastrophic event during cancer development
  publication-title: Cell
  doi: 10.1016/j.cell.2010.11.055
– volume: 45
  start-page: 927
  year: 2013
  end-page: 932
  ident: CR31
  article-title: Recurrent somatic alterations of and in pilocytic astrocytoma
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2682
– volume: 64
  start-page: 7773
  year: 2004
  end-page: 7779
  ident: CR69
  article-title: Pten loss causes hypertrophy and increased proliferation of astrocytes
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-04-2487
– volume: 1
  start-page: e53
  year: 2005
  ident: CR60
  article-title: SNPdetector: a software tool for sensitive and accurate SNP detection
  publication-title: PLOS Comput. Biol.
  doi: 10.1371/journal.pcbi.0010053
– volume: 45
  start-page: 242
  year: 2013
  end-page: 252
  ident: CR63
  article-title: The genomic landscape of hypodiploid acute lymphoblastic leukemia
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2532
– volume: 8
  start-page: 652
  year: 2011
  end-page: 654
  ident: CR58
  article-title: CREST maps somatic structural variation in cancer genomes with base-pair resolution
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.1628
– volume: 70
  start-page: 512
  year: 2010
  ident: BFng2938_CR10
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-09-1851
– volume: 29
  start-page: 418
  year: 2001
  ident: BFng2938_CR68
  publication-title: Nat. Genet.
  doi: 10.1038/ng747
– volume: 72
  start-page: 1068
  year: 2012
  ident: BFng2938_CR24
  publication-title: Dev. Neurobiol.
  doi: 10.1002/dneu.22022
– volume: 8
  start-page: 652
  year: 2011
  ident: BFng2938_CR58
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.1628
– volume: 44
  start-page: 251
  year: 2012
  ident: BFng2938_CR4
  publication-title: Nat. Genet.
  doi: 10.1038/ng.1102
– volume: 13
  start-page: 212
  year: 2011
  ident: BFng2938_CR16
  publication-title: Neuro-oncol.
  doi: 10.1093/neuonc/noq158
– volume: 488
  start-page: 43
  year: 2012
  ident: BFng2938_CR47
  publication-title: Nature
  doi: 10.1038/nature11213
– volume: 23
  start-page: 558
  year: 2013
  ident: BFng2938_CR43
  publication-title: Brain Pathol.
  doi: 10.1111/bpa.12042
– volume: 12
  start-page: 153
  year: 2010
  ident: BFng2938_CR7
  publication-title: Neuro-oncol.
  doi: 10.1093/neuonc/nop001
– volume: 22
  start-page: 5100
  year: 2002
  ident: BFng2938_CR67
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.22.14.5100-5113.2002
– volume: 444
  start-page: 761
  year: 2006
  ident: BFng2938_CR26
  publication-title: Nature
  doi: 10.1038/nature05349
– volume: 27
  start-page: 7918
  year: 2007
  ident: BFng2938_CR56
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.00099-07
– volume: 45
  start-page: 1141
  year: 2013
  ident: BFng2938_CR32
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2734
– volume: 15
  start-page: 5753
  year: 2009
  ident: BFng2938_CR38
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-08-3210
– volume: 27
  start-page: 985
  year: 2013
  ident: BFng2938_CR41
  publication-title: Genes Dev.
  doi: 10.1101/gad.217778.113
– volume: 15
  start-page: 5962
  year: 2009
  ident: BFng2938_CR29
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-08-0651
– volume: 482
  start-page: 226
  year: 2012
  ident: BFng2938_CR3
  publication-title: Nature
  doi: 10.1038/nature10833
– volume: 488
  start-page: 100
  year: 2012
  ident: BFng2938_CR49
  publication-title: Nature
  doi: 10.1038/nature11284
– volume: 23
  start-page: 1149
  year: 2008
  ident: BFng2938_CR1
  publication-title: J. Child Neurol.
  doi: 10.1177/0883073808321765
– volume: 33
  start-page: 2413
  year: 2013
  ident: BFng2938_CR21
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.01595-12
– volume: 16
  start-page: 3368
  year: 2010
  ident: BFng2938_CR15
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-10-0438
– volume: 161
  start-page: 140
  year: 2010
  ident: BFng2938_CR23
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/j.1476-5381.2010.00871.x
– volume: 28
  start-page: 1337
  year: 2010
  ident: BFng2938_CR12
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2009.25.5463
– volume: 288
  start-page: 27940
  year: 2013
  ident: BFng2938_CR37
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M113.475301
– volume: 287
  start-page: 36990
  year: 2012
  ident: BFng2938_CR20
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M112.365932
– volume: 93
  start-page: 1355
  year: 1999
  ident: BFng2938_CR35
  publication-title: Blood
  doi: 10.1182/blood.V93.4.1355
– volume: 12
  start-page: 542
  year: 2007
  ident: BFng2938_CR34
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.11.012
– volume: 1
  start-page: e53
  year: 2005
  ident: BFng2938_CR60
  publication-title: PLOS Comput. Biol.
  doi: 10.1371/journal.pcbi.0010053
– volume: 70
  start-page: 298
  year: 2010
  ident: BFng2938_CR28
  publication-title: Dev. Neurobiol.
  doi: 10.1002/dneu.20769
– volume: 110
  start-page: 6021
  year: 2013
  ident: BFng2938_CR54
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1303607110
– volume: 108
  start-page: 395
  year: 2012
  ident: BFng2938_CR39
  publication-title: J. Neurooncol.
  doi: 10.1007/s11060-012-0842-3
– volume: 38
  start-page: 525
  year: 2006
  ident: BFng2938_CR19
  publication-title: Nat. Genet.
  doi: 10.1038/ng1783
– volume: 481
  start-page: 329
  year: 2012
  ident: BFng2938_CR57
  publication-title: Nature
  doi: 10.1038/nature10733
– volume: 45
  start-page: 927
  year: 2013
  ident: BFng2938_CR31
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2682
– volume: 152
  start-page: 1226
  year: 2013
  ident: BFng2938_CR71
  publication-title: Cell
  doi: 10.1016/j.cell.2013.02.023
– volume: 13
  start-page: 69
  year: 2008
  ident: BFng2938_CR27
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.12.005
– volume: 45
  start-page: 602
  year: 2013
  ident: BFng2938_CR30
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2735
– volume: 79
  start-page: 871
  year: 1984
  ident: BFng2938_CR62
  publication-title: J. Am. Stat. Assoc.
  doi: 10.1080/01621459.1984.10477105
– volume: 30
  start-page: 3391
  year: 2011
  ident: BFng2938_CR45
  publication-title: Oncogene
  doi: 10.1038/onc.2011.121
– volume: 201
  start-page: 511
  year: 2013
  ident: BFng2938_CR55
  publication-title: J. Cell Biol.
  doi: 10.1083/jcb.201210031
– volume: 28
  start-page: 3061
  year: 2010
  ident: BFng2938_CR9
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2009.26.7252
– volume: 21
  start-page: 168
  year: 2012
  ident: BFng2938_CR65
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2011.12.023
– volume: 9
  start-page: 83
  year: 2011
  ident: BFng2938_CR18
  publication-title: Curr. Osteoporos. Rep.
  doi: 10.1007/s11914-011-0046-3
– volume: 481
  start-page: 157
  year: 2012
  ident: BFng2938_CR46
  publication-title: Nature
  doi: 10.1038/nature10725
– volume: 125
  start-page: 373
  year: 2013
  ident: BFng2938_CR48
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-012-1070-9
– volume: 93
  start-page: 488
  year: 1999
  ident: BFng2938_CR66
  publication-title: Blood
  doi: 10.1182/blood.V93.2.488.402k17_488_499
– volume: 29
  start-page: 3999
  year: 2011
  ident: BFng2938_CR8
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2011.35.5677
– volume: 71
  start-page: 4106
  year: 2011
  ident: BFng2938_CR70
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-10-3597
– volume: 7
  start-page: e30313
  year: 2012
  ident: BFng2938_CR11
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0030313
– volume: 8
  start-page: 195
  year: 1998
  ident: BFng2938_CR61
  publication-title: Genome Res.
  doi: 10.1101/gr.8.3.195
– volume: 45
  start-page: 242
  year: 2013
  ident: BFng2938_CR63
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2532
– volume: 61
  start-page: 7404
  year: 2001
  ident: BFng2938_CR2
  publication-title: Cancer Res.
– volume: 340
  start-page: 857
  year: 2013
  ident: BFng2938_CR42
  publication-title: Science
  doi: 10.1126/science.1232245
– volume: 151
  start-page: 56
  year: 2012
  ident: BFng2938_CR52
  publication-title: Cell
  doi: 10.1016/j.cell.2012.08.026
– volume: 28
  start-page: 15
  year: 1995
  ident: BFng2938_CR36
  publication-title: Genomics
  doi: 10.1006/geno.1995.1100
– volume: 151
  start-page: 68
  year: 2012
  ident: BFng2938_CR51
  publication-title: Cell
  doi: 10.1016/j.cell.2012.08.033
– volume: 125
  start-page: 659
  year: 2013
  ident: BFng2938_CR40
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-013-1095-8
– volume: 488
  start-page: 106
  year: 2012
  ident: BFng2938_CR50
  publication-title: Nature
  doi: 10.1038/nature11329
– volume: 25
  start-page: 1754
  year: 2009
  ident: BFng2938_CR59
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp324
– volume: 22
  start-page: 425
  year: 2012
  ident: BFng2938_CR17
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.08.024
– volume: 24
  start-page: 660
  year: 2013
  ident: BFng2938_CR44
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2013.10.006
– volume: 144
  start-page: 27
  year: 2011
  ident: BFng2938_CR53
  publication-title: Cell
  doi: 10.1016/j.cell.2010.11.055
– volume: 119
  start-page: 3462
  year: 2009
  ident: BFng2938_CR22
  publication-title: J. Clin. Invest.
– volume: 25
  start-page: 1196
  year: 2007
  ident: BFng2938_CR6
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2006.07.8626
– volume: 22
  start-page: 722
  year: 2008
  ident: BFng2938_CR25
  publication-title: Genes Dev.
  doi: 10.1101/gad.1636408
– volume: 64
  start-page: 7773
  year: 2004
  ident: BFng2938_CR69
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-04-2487
– ident: BFng2938_CR14
  doi: 10.1038/nature07385
– volume: 15
  start-page: 215
  year: 2005
  ident: BFng2938_CR33
  publication-title: Semin. Cancer Biol.
  doi: 10.1016/j.semcancer.2005.01.003
– volume: 321
  start-page: 1807
  year: 2008
  ident: BFng2938_CR13
  publication-title: Science
  doi: 10.1126/science.1164382
– volume: 22
  start-page: 589
  year: 2004
  ident: BFng2938_CR64
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt957
– volume: 124
  start-page: 439
  year: 2012
  ident: BFng2938_CR5
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-012-0998-0
– reference: 9521923 - Genome Res. 1998 Mar;8(3):195-202
– reference: 11606370 - Cancer Res. 2001 Oct 15;61(20):7404-7
– reference: 22286216 - Nat Genet. 2012 Mar;44(3):251-3
– reference: 22389665 - PLoS One. 2012;7(2):e30313
– reference: 18772890 - Nature. 2008 Oct 23;455(7216):1061-8
– reference: 23021216 - Cell. 2012 Sep 28;151(1):68-79
– reference: 18347090 - Genes Dev. 2008 Mar 15;22(6):722-7
– reference: 23530248 - Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6021-6
– reference: 22489086 - Dev Neurobiol. 2012 Jul;72(7):1068-84
– reference: 22832583 - Nature. 2012 Aug 2;488(7409):100-5
– reference: 23649806 - J Cell Biol. 2013 May 13;201(4):511-21
– reference: 9885210 - Blood. 1999 Jan 15;93(2):488-99
– reference: 20150382 - Neuro Oncol. 2010 Feb;12(2):153-63
– reference: 9949179 - Blood. 1999 Feb 15;93(4):1355-63
– reference: 20068183 - Cancer Res. 2010 Jan 15;70(2):512-9
– reference: 21340697 - Curr Osteoporos Rep. 2011 Jun;9(2):83-8
– reference: 23572558 - Mol Cell Biol. 2013 Jun;33(12):2413-24
– reference: 16642017 - Nat Genet. 2006 May;38(5):525-7
– reference: 17401009 - J Clin Oncol. 2007 Apr 1;25(10):1196-208
– reference: 18952581 - J Child Neurol. 2008 Oct;23(10):1149-59
– reference: 19737945 - Clin Cancer Res. 2009 Sep 15;15(18):5753-61
– reference: 18167341 - Cancer Cell. 2008 Jan;13(1):69-80
– reference: 21215367 - Cell. 2011 Jan 7;144(1):27-40
– reference: 24840074 - Nat Rev Clin Oncol. 2014 Jun;11(6):300
– reference: 24769718 - Nat Genet. 2014 May;46(5):421-2
– reference: 22820256 - Nature. 2012 Aug 2;488(7409):106-10
– reference: 23817572 - Nat Genet. 2013 Aug;45(8):927-32
– reference: 19755385 - Clin Cancer Res. 2009 Oct 1;15(19):5962-7
– reference: 23798677 - J Biol Chem. 2013 Sep 27;288(39):27940-50
– reference: 15826836 - Semin Cancer Biol. 2005 Jun;15(3):215-23
– reference: 22237022 - Nature. 2012 Jan 19;481(7381):329-34
– reference: 17875932 - Mol Cell Biol. 2007 Nov;27(22):7918-34
– reference: 19855136 - J Clin Invest. 2009 Nov;119(11):3462-72
– reference: 20479398 - J Clin Oncol. 2010 Jun 20;28(18):3061-8
– reference: 21516126 - Oncogene. 2011 Aug 4;30(31):3391-403
– reference: 22340591 - Cancer Cell. 2012 Feb 14;21(2):168-80
– reference: 20718746 - Br J Pharmacol. 2010 Sep;161(1):140-9
– reference: 16261194 - PLoS Comput Biol. 2005 Oct;1(5):e53
– reference: 18068631 - Cancer Cell. 2007 Dec;12(6):542-58
– reference: 23414300 - Brain Pathol. 2013 Sep;23(5):558-64
– reference: 23021215 - Cell. 2012 Sep 28;151(1):56-67
– reference: 21931021 - J Clin Oncol. 2011 Oct 20;29(30):3999-4006
– reference: 23603901 - Genes Dev. 2013 May 1;27(9):985-90
– reference: 21507933 - Cancer Res. 2011 Jun 15;71(12):4106-16
– reference: 22661320 - Acta Neuropathol. 2012 Sep;124(3):439-47
– reference: 12077339 - Mol Cell Biol. 2002 Jul;22(14):5100-13
– reference: 23417712 - Acta Neuropathol. 2013 May;125(5):659-69
– reference: 22286061 - Nature. 2012 Feb 9;482(7384):226-31
– reference: 20186708 - Dev Neurobiol. 2010 Apr;70(5):298-303
– reference: 20570930 - Clin Cancer Res. 2010 Jul 1;16(13):3368-77
– reference: 22722829 - Nature. 2012 Aug 2;488(7409):43-8
– reference: 23498933 - Cell. 2013 Mar 14;152(6):1226-36
– reference: 7590742 - Genomics. 1995 Jul 1;28(1):15-24
– reference: 22977237 - J Biol Chem. 2012 Oct 26;287(44):36990-8
– reference: 23583981 - Nat Genet. 2013 Jun;45(6):602-12
– reference: 20142589 - J Clin Oncol. 2010 Mar 10;28(8):1337-44
– reference: 21666668 - Nat Methods. 2011 Aug;8(8):652-4
– reference: 17151667 - Nature. 2006 Dec 7;444(7120):761-5
– reference: 21138945 - Neuro Oncol. 2011 Feb;13(2):212-22
– reference: 23334668 - Nat Genet. 2013 Mar;45(3):242-52
– reference: 18772396 - Science. 2008 Sep 26;321(5897):1807-12
– reference: 15064769 - Nat Biotechnol. 2004 May;22(5):589-94
– reference: 11694875 - Nat Genet. 2001 Dec;29(4):418-25
– reference: 23539183 - Science. 2013 May 17;340(6134):857-61
– reference: 24183680 - Cancer Cell. 2013 Nov 11;24(5):660-72
– reference: 22382786 - J Neurooncol. 2012 Jul;108(3):395-402
– reference: 15520182 - Cancer Res. 2004 Nov 1;64(21):7773-9
– reference: 22237106 - Nature. 2012 Jan 12;481(7380):157-63
– reference: 23079654 - Cancer Cell. 2012 Oct 16;22(4):425-37
– reference: 23917401 - Nat Genet. 2013 Oct;45(10):1141-9
– reference: 19451168 - Bioinformatics. 2009 Jul 15;25(14):1754-60
– reference: 23184418 - Acta Neuropathol. 2013 Mar;125(3):373-84
SSID ssj0014408
Score 2.6403525
Snippet Suzanne Baker, Jinghui Zhang and colleagues report the identification of recurrent somatic mutations in the bone morphogenetic protein (BMP) receptor ACVR1 in...
Pediatric high-grade glioma (HGG) is a devastating disease with a less than 20% survival rate 2 years after diagnosis. We analyzed 127 pediatric HGGs,...
Pediatric high-grade glioma (HGG) is a devastating disease with a less than 20% survival rate 2 years after diagnosis (1). We analyzed 127 pediatric HGGs,...
Pediatric high-grade glioma (HGG) is a devastating disease with a two-year survival of less than 20%1. We analyzed 127 pediatric HGGs, including diffuse...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 444
SubjectTerms 45
45/23
45/91
631/208/514/1948
64
64/116
64/60
692/699/67/1922
Activin Receptors, Type I - genetics
Age
Agriculture
Animal Genetics and Genomics
Animals
Bioinformatics
Biomedicine
Brain Stem Neoplasms - genetics
Cancer
Cancer Research
Child
Children & youth
Cohort Studies
Computational Biology
Gene Expression Profiling
Gene Function
Gene Fusion - genetics
Genes
Genetic aspects
Genetic research
Genomes
Genomics
Glioma - genetics
Gliomas
Human Genetics
Humans
Immunoblotting
Immunohistochemistry
Kinases
letter
Medical prognosis
Microarray Analysis
Mutation
Pediatrics
Receptor, trkA - genetics
Receptor, trkB - genetics
Receptor, trkC - genetics
Reverse Transcriptase Polymerase Chain Reaction
Sequence Analysis, DNA
Signal Transduction - genetics
Statistics, Nonparametric
Survival
Tumors
Tumors in children
Zebrafish
Title The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
URI https://link.springer.com/article/10.1038/ng.2938
https://www.ncbi.nlm.nih.gov/pubmed/24705251
https://www.proquest.com/docview/1524713280
https://www.proquest.com/docview/1519842540
https://www.proquest.com/docview/1554952022
https://pubmed.ncbi.nlm.nih.gov/PMC4056452
Volume 46
WOSCitedRecordID wos000335422900009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1546-1718
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0014408
  issn: 1061-4036
  databaseCode: M7P
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1546-1718
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0014408
  issn: 1061-4036
  databaseCode: 7X7
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1546-1718
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0014408
  issn: 1061-4036
  databaseCode: BENPR
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1546-1718
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0014408
  issn: 1061-4036
  databaseCode: 8C1
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Research Library
  customDbUrl:
  eissn: 1546-1718
  dateEnd: 20241209
  omitProxy: false
  ssIdentifier: ssj0014408
  issn: 1061-4036
  databaseCode: M2O
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwELVoC1Iv5ZsGysogBCfTJE4c54RK1Qok2K4KVHuLHMcJkdpk2ewi8e-ZcT5oFtELl0grv5XteDy2M-P3CHkFbhd51UKWyUwzWCE8plyRsTwIY9-NNU-t1uHFp2g6lfN5POs-uDVdWmXvE62jzmqN38gPYZ0BP8p96b5b_GCoGoXR1U5CY4vsIEsCt6l7syGKgGrKNtop8JyEYcq99pq5PKyKt7DQydFqtOmTry1KmwmTG1FTuxid3v3fbtwje902lB61dnOf3DLVA3KnFab89ZAUYD0U6VuvSk3tbWDMk6J1TlFQZd0YWkITywqGmC5qFJsA-GVZXykKYLro9T9oVVcsRRUK5IumyI3MiqXKevQj8u305OvxB9ZJMjAtRLBiSkuTCpOmXMk8jpUXaaOVzmFmZ3CaM6HgSoPL8P0UOurmbhoakUdc80wLDPg_JttQs9knNPMCmP3GVQFPAylg36S1iQPkmzNp6GqHvO6HJtEdXznKZlwmNm7OZVIVCY6hQ-gAXLQUHX9DXuLYJkh4UWFGTaHWTZN8PLtIjriQ4ObgmPsv0JfzEehNB8praA30vb3FAH1CIq0R8mCEhGmrx8W9gSSd22iSP9bhkBdDMf4TU-EqU68R48UYOw1uxMCxP_Rhf-aQJ63pDq8GakDtQs8h0cioBwASjo9LqvK7JR6HzT3GwaHe3vyvNX38xp_e3L1nZBd2nkGbOXpAtlfLtXlObuufq7JZTshWNI_sU8JTHnsTsvP-ZDo7h1-f_bOJneW_AWgQVks
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VAiqX8iwEChjE42Sap9c5IFQBVVddlgpK1ZtJHCdEapNlswvqn-I3MpPH0iyitx44-0sce-fh2RnPB_AMzS71VQt4IhPN0UM4PLJFwlM_CF071F5ccx0ejgbjsTw6CvdX4Fd3F4bKKjubWBvqpNT0H_kW-hm0o54r7TeT75xYoyi72lFoNGKxZ05_YshWvR6-w9_3uevuvD94u8tbVgGuhfBnPNLSxMLEsRfJNAwjZ6CNjnSKwplgQGIC4UUapd51Y5zSTu04MCIdeNpLtKCcNb73ElzGY4Qr61LB_UXWgtib6-yqoLiM0qLrzbV2uVVkr9Cxyp73W_YBZ5zgcoHmUpa2dn471_-3bbsB6-0xm203enETVkxxC642xJuntyFD7WDUnvYk16y-7Ux1YKxMGRHGzCvDctySvEARZpOSyDQQfpyXJxFDMJt0_CasKAseE8sG9cNm1PuZZ9Mo6dB34MuFrHIDVnFmcw9Y4vho3Ywd-V7sS4HnQq1N6FM_PRMHtrbgRScKSrf92IkW5FjVdQGeVEWmSGYsYAvgpGlB8jfkKcmSooYeBVUMZdG8qtTw46Ha9oREM45h_L9Anz_1QC9bUFri1-Dam1sauCZqFNZDbvaQaJZ0f7gTSNWaxUr9kUYLniyG6Ukq9StMOSeME1Ju2D8XE2Bg7-L504K7jaostgZnIG5Gx4JBT4kWAGqo3h8p8m91Y3UMXijPj_N26nbm0_s7fv_85T2Gtd2DDyM1Go73HsA1PGX7TZXsJqzOpnPzEK7oH7O8mj6qLQiDrxete78B8JuvwQ
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFH4qZRGXskOggEEsJzPZ4xwQqlpGjFoNFdCqN5M4TojUJsNkBtS_xq_jvWw0g-itB87-Zhw7b7Hzlg_gBZpd6qvm8UQkiqOHsHhk-glPXS-0zVA5cc11eLgXTKfi6CjcX4NfXS0MpVV2NrE21Emp6Bv5CP0M2lHHFuYobdMi9nfG72bfOTFIUaS1o9NoRGRXn_7E61v1drKD7_qlbY_ff9n-wFuGAa58313wSAkd-zqOnUikYRhZgdIqUikKaoKXE-35TqRQA2w7xunN1Iw97aeBo5xE-RS_xv-9BJcDB6WYqtS3-_QSipk2ZXg-3dEoRLrRlLiLUZG9QScrBp5w1R-ccYiryZorEdvaEY5v_M9beBM22uM322r05Ras6eI2XG0IOU_vQIZaw6ht7UmuWF0FTflhrEwZEcksK81y3J68QNFms5JINhB-nJcnEUMwm3W8J6woCx4T-wb1yWbUE5pn8yjp0Hfh4EJWeQ_WcWb9AFhiuWj1tBm5TuwKH8-LSunQpT57OvZMZcCrTiykavu0E13IsazzBRwhi0yS_BjAeuCsaU3yN-Q5yZWkRh8Fve8sWlaVnHw8lFuOL9C84_X-X6DPnwag1y0oLfFpcO1N9QauiRqIDZCbAySaKzUc7oRTtuaykn8k04Bn_TD9klIAC10uCWOFFDN2z8V4eOG38VxqwP1GbfqtwRmIs9EyIBgoVA-gRuvDkSL_Vjdcx0sNxf9x3k71zjz6cMcfnr-8p3ANVU7uTaa7j-A6Hr7dJnl2E9YX86V-DFfUj0VezZ_UxoTB14tWvd-FVrg3
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+genomic+landscape+of+diffuse+intrinsic+pontine+glioma+and+pediatric+non-brainstem+high-grade+glioma&rft.jtitle=Nature+genetics&rft.date=2014-05-01&rft.pub=Nature+Publishing+Group+US&rft.issn=1061-4036&rft.eissn=1546-1718&rft.volume=46&rft.issue=5&rft.spage=444&rft.epage=450&rft_id=info:doi/10.1038%2Fng.2938&rft.externalDocID=10_1038_ng_2938
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1061-4036&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1061-4036&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1061-4036&client=summon